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Preface 
 
 
 
This report was written within the framework of the research project, 'Organisation of the 
conservation of agricultural genetic resources', financed by the LNV/DLO research pro-
gramme 'Integratie Mens- en Maatschappijwetenschappen (Gamma)'. Researchers from 
LEI (Derek Eaton and Jos Bijman) collaborated with CGN (Electra Kalaugher). The objec-
tive of this project was to analyse the institutional organisation of the conservation of 
agricultural genetic resources in the Netherlands. 
 This report provides detailed background material to a separate LEI report (No. 
7.03.14), Conservering van genetische bronnen voor de landbouw in Nederland; Organi-
satie en institutionele inbedding (Conservation of agricultural genetic resources in the 
Netherlands; Organisation and institutional framework). That report describes the principal 
actors involved in the conservation and management of agricultural genetic resources in 
the Netherlands. Given the significant implications of international agreements and poli-
cies for the determination of Dutch policy, as well as their effects on various other actors, 
this current report was written and produced as a separate document given the considerable 
complexity of the issues involved. 
 A draft of this report was read and commented on by Rob van Raalte of the Depart-
ment of International Affairs of the Dutch Ministry of Agriculture, Nature Management 
and Food Quality (LNV) and also by Chris van Winden of the Ministry's Department of 
Agriculture. The authors would like to thank these individuals for their detailed and con-
structive comments. 
 
 
 
 
 
Prof. Dr. L.C. Zachariasse 
Director General LEI B.V. 
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Summary 
 
 
 
This report summarises the international agreements relating to plant genetic resources for 
food and agriculture. The various obligations arising from these conventions and treaties 
are reviewed with attention for potential interactions between such obligations. In addition, 
the implications for genetic resources policy in the Netherlands are outlined and existing 
initiatives to fulfill these obligations are highlighted.  
 Policy issues related to plant genetic resources are socially, technically and scientifi-
cally complex. They are also often highly controversial, particularly in light of recent 
developments in genetic research, which have led to an increase in the perceived commer-
cial value of plant genetic resources. These developments, coupled with a longstanding 
mutual interdependence between countries for genetic resources, have reinforced the 
global nature of the topic and highlighted the range of different groups and individuals 
with vested interests in related issues, including breeders, agribusinesses, farmers, consum-
ers, environmentalists, governments and international organisations. 
 A number of international instruments have been developed over the years in dif-
ferent fora to address these complex issues. The present array of international instruments 
can be considered in two main categories, according to their objectives:  
- Those working towards the conservation and sustainable use of plant genetic re-
sources and the equitable sharing of benefits arising from their use, such as the 
Convention on Biological Diversity (CBD), the FAO Global Plan of Action on Plant 
Genetic Resources (GPA), and more recently the International Treaty on Plant Ge-
netic Resources for Food and Agriculture (IT-PGRFA); and  
- Those aiming to protect intellectual property, such as the Agreement on Trade Re-
lated Aspects of Intellectual Property Rights (TRIPS), (inter)national patent 
legislation, and sui generis systems of intellectual property protection such as the 
plant breeder's right under the International Convention for the Protection of New 
Varieties of Plants (the UPOV Convention). 
 
Convention on Biological Diversity (CBD) 
 The CBD was signed by over 150 governments at the 1992 United Nations Confer-
ence on Environment and Development (UNCED) and came into force in 1993. The 
objectives of the CBD are the conservation of biological diverstiy, the sustainable use of its 
components, and the fair and equitable sharing of the benefits arising from the use of ge-
netic resources. The CBD recognises the national sovereignty of each country over genetic 
resources originating within its jurisdiction, and provides a framework of general princi-
ples for regulating the international exchange of genetic resources, referred to as 'mutually 
agreed terms' (MAT) and 'prior informed consent' (PIC). In 2002, the countries that have 
signed the CBD adopted the Bonn Guidelines on Access to Genetic Resources and the Fair 
and Equitable Sharing of the Benefits Arising out of their Utilization. These provide guid-
ance for the development of national legislation and on contracts for benefit-sharing. The 
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Bonn Guidelines are voluntary and do not strictly entail legal obligations on parties in-
volved in negotiating access and benefit-sharing. The Guidelines allow for such parties to 
take legal, administrative or policy measures to support compliance with PIC and MAT. 
Provisions are also suggested for access and benefit sharing in material transfer agreements 
(MTA), the name given to contracts governing the exchange of genetic resources. 
 While the CBD concerns all forms of biological diversity, domesticated and culti-
vated species of plants and animals have specific characteristics that complicate the 
implementation of the Convention. Most importantly, the widespread exchange and use of 
these species in the past makes the identification of a 'country of origin' quite difficult. The 
special nature of agricultural genetic resources has thus been recognised within the CBD. 
 
Global System for Plant Genetic Resources 
The Global System for Plant Genetic Resources refers to a collection of programs and 
plans overseen by the Commission on Genetic Resources for Food and Agriculture 
(CGRFA) of the United Nations Food and Agriculture Organization (FAO). A key element 
is the Global Plan of Action for the Conservation and Sustainable Utilization of Plant Ge-
netic Resources for Food and Agriculture (GPA), adopted in 1996. The GPA consists of a 
recommendations and activities that is intended to act as a framework and catalyst for ini-
tiatives at various levels to conserve and manage genetic resources. 
 
International Treaty on Plant Genetic Resources for Food and Agriculture (IT-PGRFA) 
The IT-PGRFA was concluded in 2001 and will come into force once it has been ratified 
by forty countries. The IT-PGRFA complements the GPA, and can even be seen as part of 
the Global System. The new treaty is intended to resolve specific issues relating to agricul-
tural biodiversity in the CBD.  
 The IT-PGRFA establishes a multilateral system (MS) for access and benefit-
sharing. The MS applies to all plant genetic resources of a specified list of species and that 
are in the public domain. The list of species is referred to in Annex 1 of the IT-PGRFA and 
includes most major food crops and a list of important forages. The compiling of the list 
was a result of extensive negotiations and some notable corps, such as groundnut and to-
mato, was withheld. 
 Facilitated access to material held in the public domain of Annex 1 species is to be 
provided pursuant to a standard material transfer agreement (MTA). This will not entail 
any costs exceeding those required for handling and administration of the transfer. Fur-
thermore, the MTA will require that recipients of material only have an obligation to share 
commercial benefits from the use of the material in breeding of new varieties if the avail-
ability of such new material is restricted, in particular through patent protection. Protection 
by means of plant breeders' rights will not automatically trigger any benefit-sharing provi-
sions. 
 The IT-PGRFA also incorporates the important germplasm collections of the interna-
tional agricultural research centres (IARCs) of the Consultative Group on International 
Agricultural Research (CGIAR). The vast majority of the collections of the IARCs consist 
of Annex 1 species but current collections of other species held by IARCs will also be 
made available according to the same terms.  
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 Material of non-Annex 1 species appearing in the public domain after the entry into 
force of the CBD will be subject to the terms of the CBD's Bonn Guidelines, and thus bi-
lateral negotiation between the parties concerned. These terms will also apply to material 
of non-Annex 1 species acquired by IARCs after the entry into force of the IT-PGRFA. 
But the specific terms for material of non-Annex 1 species (not held by IARCs) collected 
before the entry into force of the CBD remain unclear and are not specified.  
 With the entry into force of the IT-PGRFA, there will thus be effectively three dif-
ferent groups of germplasm within the public domain: the MS, non-Annex 1 species 
subject to the CBD's Bonn Guidelines, and those with unclear status. The IT-PGRFA is 
thus an attempt to secure continued unencumbered exchange of plant genetic resources for 
breeding purposes. It is possible that further species may be added to the MS in the future. 
 
Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) 
The second grouping of international agreements concerns intellectual property rights 
(IPR). The most important is arguably TRIPS, which came into force in 1995 under the 
umbrella agreement establishing the World Trade Organization (WTO). The TRIPS 
Agreement applies thus to all WTO members. TRIPS establishes minimum standards for 
all forms of IPR protection.  
 TRIPS requires countries to offer patent protection for all inventions but allows an 
exclusion to be made for plants and animals (other than micro-organisms). Protection is 
however required for plant varieties, if not by patents, then at least by an effective sui 
generis system. Plant breeders' rights are considered to be the relevant option for such a 
system although TRIPS does not prescribe any particular variants. 
 Although TRIPS does allow members to preclude plants from patentability, the pat-
ent protection must be available for inventions pertaining to non-biological and 
microbiological processes for the production of plants and animals. This includes various 
applications developed in biotechnology, including genetic modification. 
 Within the European Union, national compliance with the these provisions of TRIPS 
is meant to be ensured by EC Directive 98/44/EC on the legal protection of biotechnologi-
cal inventions. Directive 98/44/EC states that plant and animal varieties are not patentable, 
but patents are to be made available for biotechnological inventions that are not confined to 
a single plant or animal variety. The Directive also clarifies the relationship between plant 
variety protection and patent protection where these two may overlap. 
 
World Intellectual Property Organization (WIPO)  
WIPO is a UN specialised agency that administers international treaties dealing with dif-
ferent aspects of intellectual property protection and promoting international harmonisation 
of IPR systems. In the area of PGRFA, WIPO is investigating, in collaboration with other 
international bodies, possibilities for the protection of the property rights of indigenous and 
traditional communities. WIPO is also collaborating with UPOV on the relationship be-
tween plant variety protection and patent protection for biotechnological inventions. 
 
International Union for the Protection of New Varieties of Plants (UPOV) 
UPOV is an international convention establishing agreement between its members on spe-
cific provisions of national plant variety protection legislation. Successive Acts of the 
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UPOV Convention in 1961, 1972, 1978 and 1991 have incrementally extended the scope 
of protection to be granted with a Plant Breeder's Right (PBR). Two major limitations to 
this protection were initially the breeders' exemption and the farmers' privilege. The breed-
ers' exemption allows the use of a protected variety in further, commercial breeding 
activities. The farmers' privilege allows farmers to use harvested seed from cultivated pro-
tected varieties. The 1991 UPOV Act restricted the farmers' privilege to an optional 
exception. Partly for this reason, many developing countries have opted for the 1978 Act. 
 
Relationship between the agreements 
The international agreements relating to agricultural plant genetic resources were devel-
oped at different periods in time, and address an evolving policy agenda with respect to 
conservation, use and appropriation of benefits. In general, the agreements are complimen-
tary. The IT-PGRFA and the CBD recognise the common property nature, whether 
national or international, of existing plant varieties and establish conditions for their inter-
national exchange for use in breeding efforts. UPOV and TRIPS have allowed the creation 
of (intellectual) property rights, to be held by individual stakeholders such as companies, 
insitutes and individuals, over newly created varieties. Uncertainties remain though as to 
the terms for access and exchange to some plant genetic resources which are not covered 
by the IT-PGRFA and also potentially not by the CBD. 
 The manner in which governments implement legislation to respect the conditions 
placed on the use of genetic resources by the IT-PGRFA and the CBD needs to take into 
account provisions of the TRIPS Agreements, and possibly UPOV. Under both the CBD 
and the IT-PGRFA, restrictions and conditions will be placed on the receiver of genetic 
material with respect to intellectual property protection that may subsequently be sought. 
Such restrictions can be incorporated into contractual agreements, such as Material Trans-
fer Agreements. But the Bonn Guidelines for Access and Benefit-Sharing of the CBD also 
requires governments to take 'appropriate legal, administrative, or policy measures to sup-
port compliance with PIC and MAT. It has been suggested that governments should amend 
their IPR legislation for such purposes. Some amendments could be in conflict though with 
TRIPS and potentially with other IPR treaties. This would be the case, for example, for a 
requirement that patent applicants disclose the geographical origin or source of any bio-
logical material covered in a patent application, as a condition for granting patent 
protection. Because of conflicts with TRIPS, such a disclosure requirement has been pro-
posed, for example in the EC Directive 98/44/EC, but in a such a way that it not be 
considered a formal condition for patent approval. Avoiding conflicts between these vari-
ous agreements requires a proactive examination of the interaction of proposed national 
legislation. 
 
Implications for the Netherlands 
The Netherlands participates in all of the instruments described in this document and con-
siders that 'international obligations regarding intellectual property, trade, agriculture and 
biodiversity are mutually reinforcing'. Government policy relating to agricultural genetic 
resources is presented in the document Sources of Our Existence, adopted in 2002. Dutch 
government policy documents on nature management and the environment, Nature for 
People, People for Nature and the 4th National Environmental Policy Plan are also relevant. 
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In addition, the International Policy Programme Biodiversity 2002-2006 indicates how a 
number of biodiversity-related policy commitments will be implemented, concentrating on 
international aspects. 
 Government policy is that the private sector, researchers and other organisations or 
stakeholders will be expected to assume most of the responsibility for implementing policy 
commitments. The government facilitates and supports this implementation, with an em-
phasis on national and international exchange of expertise and information. The 
government has thus concluded that additional legislation on the subject of genetic re-
sources is not appropriate or necessary at this moment. This strategy depends on 
transparency over the management and use of genetic resources. In this regard, the Nether-
lands has supported at European level the requirement for disclosure of origin of biological 
material in patent applications. 
 To support the implementation of policy, the government has supported the estab-
lishment of a Genetic Resources Platform. This is to consist of representatives from the 
business sector, research organizations, social organizations and the government. The plat-
form is to address, among other issues, the development and use of codes of conduct for 
various actors in order to support the implementation of government policy. 
 The Netherlands is thus an example of a country of the North trying to promote a so-
lution with minimal adjustments to existing IPR agreements, which many developing 
countries would prefer to see. At this point, it is difficult to predict whether this approach 
will achieve the results desired by various stakeholders. 
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1. Introduction 
 
 
 
Policy issues related to plant genetic resources are socially, technically and scientifically 
complex. They are also often highly controversial, particularly in light of recent develop-
ments in genetic research, which have led to an increase in the perceived commercial value 
of plant genetic resources. These developments, coupled with a longstanding mutual inter-
dependence between countries for genetic resources, have reinforced the global nature of 
the topic and highlighted the range of different groups and individuals with vested interests 
in related issues, including breeders, agribusinesses, farmers, consumers, environmental-
ists, governments and international organizations. 
 A number of international instruments have been developed over the years in dif-
ferent fora to address these complex issues, often with potentially conflicting goals. The 
present array of international instruments can be considered in two main categories, ac-
cording to their objectives:  
- Those working towards the conservation and sustainable use of plant genetic re-
sources and the equitable sharing of benefits arising from their use, such as the 
Convention on Biological Diversity (CBD), the FAO Global Plan of Action on Plant 
Genetic Resources (GPA), and more recently the International Treaty on Plant Ge-
netic Resources for Food and Agriculture (IT-PGRFA); and  
- Those aiming to protect intellectual property, such as the agreement on Trade Re-
lated Aspects of Intellectual Property Rights (TRIPS), (inter)national patent 
legislation, and sui generis systems of intellectual property protection such as the 
plant breeder's right under the International Convention for the Protection of New 
Varieties of Plants (the UPOV Convention). 
 
 The diversity of interests in the issues at stake is reflected both in government repre-
sentation in the negotiation of the instruments and in the international organisations that 
provide fora for negotiations. The first group of instruments was negotiated by ministries 
of environment and agriculture and is overseen and influenced by international organiza-
tions such as the United Nations Environmental Programme (UNEP) and the Food and 
Agriculture Organization of the United Nations (FAO). The second group was predomi-
nantly negotiated by ministries of economic affairs, in association with the World Trade 
Organization (WTO) and the World Intellectual Property Organization (WIPO).  
 In order to formulate sound national policy that fulfils international obligations under 
the different agreements, the relationships within and between these two categories of in-
struments must be clarified and reinterpreted at the national level. This report examines the 
array of obligations under the different instruments and what they mean for plant genetic 
resources policy in the Netherlands.  
 The first section of this report provides an overview of the international policy 
frameworks for the conservation of plant genetic resources, including their objectives, 
scope and means of implementation, as well as their relationship to each other and to the 
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international organizations that oversee their implementation. The second section examines 
the potential impact of these international treaties, agreements and organizations on Dutch 
government policy. 
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2. International Agreements 
 
 
 
2.1 The Convention on Biological Diversity 
 
Background and objectives 
The Convention on Biological Diversity (CBD) was signed by over 150 governments at 
the 1992 United Nations Conference on Environment and Development (UNCED) in Rio 
de Janeiro, and came into force in 1993. The CBD recognized for the first time that the 
conservation of biological diversity is 'a common concern of humankind'. The Convention 
is a legally binding agreement that applies to all ecosystems, species, and genetic re-
sources. As of October 2002, the CBD has 186 Parties, including the Netherlands and the 
European Union.1 Its objectives are the conservation of biological diversity, the sustainable 
use of its components, and the fair and equitable sharing of the benefits arising out of the 
utilization of genetic resources, including by appropriate access to genetic resources and by 
appropriate transfer of relevant technologies, taking into account all rights over those re-
sources and to technologies, and by appropriate funding.2  
 
Implementation 
The CBD is implemented through thematic work programs - at the national level by gov-
ernments, and at the regional and international levels through regional and international 
agencies. A number of international structures support its implementation, including:  
- the Conference of the Parties (COP), the governing body of the Convention, which 
advances implementation of the Convention through the decisions it takes at its peri-
odic meetings (to date the Conference of the Parties has held 6 ordinary meetings, 
and one extraordinary meeting, resulting in a total of 146 procedural and substantive 
decisions); 
- the Subsidiary Body on Scientific, Technical and Technological Advice (SBSTTA), 
which is composed of experts and provides advice to the COP; 
- the Secretariat, which organizes meetings, facilitates international collaboration and 
responds to requests from the COP; 
- the Clearing-House Mechanism for Scientific and Technical Cooperation (CHM); 
and 
- a financial mechanism operated by the Global Environment Facility (GEF). 
 
 In addition to the thematic work programs of the CBD, there are a number of cross-
cutting issues addressed by the CBD of relevance to all thematic areas, including biosafety; 
access to genetic resources; traditional knowledge, innovations and practices (Article 8(j)); 
intellectual property rights; public education and awareness; incentives; and others. Some 
                                                     
1 See the website of the CBD at www.biodiv.org 
2 Convention on Biological Diversity, Article 1 
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cross cutting initiatives directly support work under thematic programs, while others can 
develop more independently - for example, the negotiations for a protocol on biosafety. 
 
Relationships with other international agreements and organisations 
One of the five thematic programs of the CBD is the program of work on agricultural bio-
diversity. The CBD Secretariat works closely with FAO on agricultural biodiversity-
related issues, a relationship that has been formalized through a memorandum of under-
standing. The program of work encompasses agreed FAO plans and programs such as the 
Global Plan of Action for the Conservation and Sustainable Use of Plant Genetic Re-
sources for Food and Agriculture and the State of the World reports on plant and animal 
genetic resources. In particular, a close relationship has been maintained between the CBD 
and FAO in the context of the negotiations for the revision of the International Undertaking 
on Plant Genetic resources (IU) in harmony with the CBD. The revision of the IU was 
based on the Nairobi Final Act of the Conference for the Adoption of the Agreed Text of 
the Convention on Biological Diversity (1993), which recognized, the need to seek solu-
tions to outstanding matters concerning plant genetic resources within the Global System 
for the Conservation and Use of Plant Genetic Resources for Food and Sustainable Agri-
culture, in particular (a) access to ex-situ collections not acquired in accordance with this 
Convention; and (b) the question of Farmers' Rights. 
 At its second meeting in Jakarta, 1995, the COP took note of the Global System on 
Plant Genetic Resources for Food and Agriculture, recalled the Nairobi Final act and de-
clared its support for the adaptation of the International Undertaking on Plant Genetic 
Resources.1 Subsequent meetings have urged the completion of these negotiations, result-
ing in the International Treaty on Plant Genetic Resources for Food and Agriculture (IT-
PGRFA; Section 2.3).  
 The CBD Secretariat has signed memoranda of understanding outlining areas for po-
tential cooperation with a number of other international organizations and secretariats of 
international environmental agreements. For example, COP Decision VI/24 invites the 
World Intellectual Property Organization (WIPO) to prepare a technical study on methods, 
consistent with obligations in treaties it administers, for requiring the disclosure of infor-
mation relating to genetic resources within patent applications, and to report its findings to 
the CBD's COP VII meeting (scheduled to take place in Kuala Lumpur in February 2004). 
 The relationship between the CBD Secretariat and the WTO is the subject of more 
tension than with other environmental organizations and agreements, in particular regard-
ing the Agreement on Trade-related Aspects of Intellectual Property Rights (TRIPS). COP 
Decision VI/24 notes the interrelationship between the provisions of TRIPS and the CBD, 
and the fact that the relationship between the TRIPS agreement and the CBD is being ex-
amined by the TRIPS Council.2  
 
Content of the CBD 
In practice, the Convention establishes a range of general, flexible obligations that empha-
size national action for conservation and sustainable use, while recognizing sovereign 
rights to set up environmental policy and exploit natural resources. It also provides a 
                                                     
1 Decision II/15 
2 In conformity with Article 19 of the Doha WTO Ministerial Declaration, adopted in November 2001 
  
 21
framework of general principles for structuring the international exchange of genetic re-
sources, based on the national sovereignty of each country over genetic resources 
originating within its jurisdiction (Bragdon and Downes 1998). It establishes that the right 
to determine access to genetic resources rests with national governments and is subject to 
national legislation. 
 National sovereignty over genetic resources is an important principle for developing 
countries, many of whom have expressed concern about the protection of their interests 
relative to bioprospecting from companies and research institutes from industrialised coun-
tries. Such organisations are more likely to have the technology for product development, 
and can obtain IPRs and patents on novel products to protect investments in research and 
development. However, the recognition of national sovereignty over genetic resources 
poses a number of problems when it comes to practical application. Plants do not stop 
growing at national boundaries and may therefore originate from more than one country, 
and in many cases it is hard to determine the 'original' origin of a plant variety, particularly 
domesticated plants that may have been considerably modified from their 'original' state. 
According to Fowler (2000): 
Due to scientific and practical problems associated with the definition of Country of Origin 
in the Convention on Biological Diversity, it is unlikely that the CBD, as it now stands, 
could be easily, efficiently, or frequently followed in regards to domesticated and culti-
vated species. 
 The CBD (Article 15) establishes that exchange of genetic resources must be based 
on 'Mutually Agreed Terms (MAT)' and subject to 'Prior Informed Consent (PIC)'.1 The in-
terpretation of these concepts into national legislation, however, is the responsibility of 
national governments. Some 50 countries (mostly developing countries) have already de-
veloped, or are developing, laws and other policy measures to regulate access to genetic 
resources and benefit sharing. Existing national and regional regulations and draft regula-
tions differ considerably in the extent to which they define PIC and MAT, and with whom 
PIC must be achieved and MAT be negotiated - national agency and/or local community or 
landowner. Benefit-sharing arrangements are also a matter to be defined on a case-by-case 
basis. 
 
PIC can be organized at three levels of law, all enforcing the sovereign right of the coun-
tries over the genetic resources (Tvedt 2002): 
1. individual agreements between the providing country and the entity using the genetic 
resources, depending on the access legislation of the providing country; 
2. by bilateral agreements between one providing country and one user country. Bilat-
eral agreement between one providing country and a group of user countries (for 
example the European Union). Bilateral agreements between a group of providing 
countries (for example a regional co-operation) and one or several user countries; 
3. multilateral agreements where several countries are both user country and providing 
country (for example can the IT-PGRFA be seen as such a multilateral prior in-
formed consent for a defined list of genetic resources)'. (Tvedt 2002, page 53). 
 
                                                     
1 See annex 1 for a fuller description of these concepts 
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 In Article 8 (j), the CBD obligates its member countries (as far as possible, as appro-
priate and subject to national legislation) to 'respect, preserve and maintain knowledge, 
innovations and practices of indigenous and local communities embodying traditional life-
styles' that are relevant to biodiversity. This important goal presents a number of practical 
problems, for which the onus for resolution falls on national governments. The political 
and social structures of traditional communities may not be consistent with western legal 
conceptions and administrative regulations. Intellectual property of local and indigenous 
communities is difficult to protect under many existing regimes because the rights involved 
are collective and intergenerational in character. Also, such rights may not satisfy the crite-
ria for IPR protection under current regimes such as novelty, inventiveness and capability 
of industrial application.1 In a number of cases (e.g. the Executive Order No. 247 of the 
Philippines2 and the Costa Rican Law on Biodiversity), Prior Informed Consent is required 
from indigenous or local communities involved as well as from the landowner and/or ad-
ministration of the protected area, as the prerequisite for receiving state permission (BMZ 
2001). This requires overcoming not only cultural and language barriers but also in many 
cases a lack of trust for any form of bioprospecting. 
 Conformation with national agreements that have been based on the CBD principles 
of PIC and MAT has generally been through bilateral agreements, often obtained after long 
and bureaucratic processes. 
 While the general principles of the CBD on access emphasize national action, they 
do not mandate bilateral transactions, nor do they preclude parties from establishing or en-
tering into a multilateral system of regulating access. The new Multilateral System of the 
IT-PGRFA may greatly facilitate access and benefit sharing for its mandated crops (see 
section 2.3), in harmony with the CBD.  
 
The Bonn Guidelines 
To assist Parties in implementing the access and benefit-sharing provisions of the Conven-
tion, the Conference of the Parties recently adopted the Bonn Guidelines on Access to 
Genetic Resources and the Fair and Equitable Sharing of the Benefits Arising out of their 
Utilization (Decision VI/24,The Hague, April 2002). The guidelines, based on the recom-
mendations of the first meeting of the Ad Hoc Open Ended Working Group on Access and 
Benefit-Sharing (Bonn, Germany, in October 2001), provide guidance on the development 
of national legislation, and on contracts for benefit-sharing. They are meant to assist Par-
ties, Governments and other stakeholders when establishing legislative, administrative or 
policy measures on access and benefit sharing and/or when negotiating contractual ar-
rangements for access and benefit sharing.3 
                                                     
1 Handbook on the Implementation of Conventions Related to Biological Diversity in Africa. (PADELIA ) 
2 Executive Order No. 247 (Philippines) www.elaw.org/resources/text.asp?ID=257 
3 CBD website on the Bonn guidelines at www.biodiv.org/programmes/socio-eco/benefit/bonn.asp 
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Box 1: Selected key elements of the Bonn Guidelines on Access to Genetic Resources and the Fair and 
Equitable Sharing of the Benefits Arising out of their Utilization  
 
- Relationship with relevant international regimes: The guidelines should be applied in a coherent 
manner 'mutually supportive' of the work of relevant international agreements and institutions (espe-
cially IT-PGRFA and taking into account the work of WIPO)… and take into account existing 
regional legislation and agreements. 
- National Focal Point: Each Party should designate one national focal point for access and benefit 
sharing and make such information available through the clearing-house mechanism. 
- Competent national authority(ies): Where established, competent national authorities may be re-
sponsible for granting access and advising on aspects such as the negotiating process, PIC and MAT 
requirements, mechanisms for participation of stakeholders, etc. 
- Responsibilities: A number of responsibilities for Parties are outlined, including review of adminis-
trative and legal measures for compliance with Article 15, reporting on access applications e.g. 
through the CHM, and ensuring harmony with environmental objectives and the needs of local and 
traditional communities (including capacity building). In general, Parties should fulfil their role in a 
transparent and objective fashion, and establish mechanisms to ensure that decisions are made avail-
able. 
- Prior Informed Consent(PIC) and Mutually Agreed Terms (MAT): Contracting parties with users 
of genetic resources under their jurisdiction should take appropriate legal, administrative, or policy 
measures to support compliance with PIC and MAT. The Guidelines also provide an outline of steps 
in the access and benefit-sharing process, including principles and elements for a PIC system and 
MAT. 
- Participation of Stakeholders: Relevant stakeholders should be consulted and their views taken into 
account in each step of the process, including in developing access and benefit-sharing arrangements 
and developing of national strategies; Appropriate consultative arrangements should be made such as 
national committees of representatives. The involvement of stakeholders should also be promoted 
through the provision of information and support for capacity building. 
- Material Transfer Agreements: The guidelines provide suggested elements for Material Transfer 
Agreements, including access and benefit-sharing as well as legal provisions. 
 
The voluntary Guidelines are viewed as a first step of an evolutionary process in the im-
plementation of relevant provisions of the Convention related to access to genetic 
resources and benefit sharing. They are to be kept under review by the COP and further re-
fined as appropriate. 
 
 
2.2 FAO and the global programs for genetic resource conservation and sustainable 
use, including the Global Plan of Action  
 
The Global System on Plant Genetic Resources 
The programs and plans monitored and coordinated by FAO on plant and animal genetic 
resources are considered vital elements that contribute to the CBD program of work on ag-
ricultural biodiversity. However, the development of the Global System on Plant Genetic 
Resources considerably predates the Convention - it began in 1983 with the establishment 
of the FAO Commission on Plant Genetic Resources (now the Commission on Genetic Re-
sources for Food and Agriculture - CGRFA). The objectives of the Global System are to 
ensure the safe conservation, and promote the availability and sustainable use of plant ge-
netic resources by providing a flexible framework for sharing benefits and burdens. The 
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CGRFA, with its Intergovernmental Technical Working Group on Plant Genetic Resources 
for Food and Agriculture, monitors and co-ordinates the development of the Global Sys-
tem.1  
 
The Global System comprises  
- the International Undertaking on Plant Genetic Resources (which formed the basis 
for the development of the IT-PGRFA); 
- the Global Plan of Action (GPA) for the Conservation and Sustainable Utilization of 
Plant Genetic Resources for Food and Agriculture; 
- the State of the World report on plant genetic resources; 
- a variety of codes of conduct and scientific standards (the Code of Conduct for 
Germplasm Collecting and Transfer, Gene Bank Standards and Guidelines, and the 
Code of Conduct on Biotechnology), and; 
- technical mechanisms (the crop and thematic networks, the International Network of 
Ex Situ Collections, and the World Information and Early Warning System). 
 
The Global Plan of Action 
A key element of the Global System is the Global Plan of Action for the Conservation and 
Sustainable Utilization of Plant Genetic Resources for Food and Agriculture (GPA), which 
was adopted by 150 countries at the Fourth International Technical Conference in Leipzig 
in 1996. The GPA is intended to provide a comprehensive global framework for action to-
wards the conservation and sustainable utilization of Plant Genetic Resources for Food and 
Agriculture (PGRFA). The GPA was developed through a country-driven process that in-
cluded 158 country reports, 12 sub-regional and regional meetings, and the preparation of 
the State of the World report on plant genetic resources. 
 The GPA is a set of recommendations and activities that follow on from the State of 
the World Report. It is intended as a framework, guide and catalyst for action at the com-
munity, national, regional and international level. It seeks to create an efficient system for 
the conservation and sustainable use of plant genetic resources, through better cooperation, 
co-ordination and planning and through the strengthening of capacities.2  
 
The GPA describes 20 Priority Activities in four areas:  
- in Situ Conservation and Development;  
- ex Situ Conservation;  
- utilization of Plant Genetic Resources; and  
- institutions and Capacity Building. 
 
 Following the Plan's adoption at the Leipzig Conference, countries and institutions 
and organization concerned with Plant Genetic Resources have begun to use their own re-
sources and existing capacity to implement the Plan. The Country Progress Report on the 
implementation of the Global Plan of Action for the Conservation and Sustainable Utiliza-
tion of Plant Genetic Resources for Food and Agriculture (CGRFA-9/02/6, 2002), based on 
a survey of 177 National Focal Points, noted that national priorities continue to concentrate 
                                                     
1 Source: FAO/CGRFA website at www.fao.org/ag/cgrfa 
2 Source: FAO/CGRFA website at www.fao.org/ag/cgrfa 
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on ex situ conservation activities (Activity areas 5 to 8), inventorying and surveying plant 
genetic resources (Activity area 1), and on building strong national programs (Activity area 
15). According to the report, a significant number of activities are being undertaken to im-
plement many activity areas of the Plan, however additional work is required at all levels 
to further implement all activity areas, particularly those related to Institutions and Capac-
ity Building. The report notes the conclusions of the Inter-governmental Technical 
Working Group on Plant Genetic Resources (ITWG-PGR) that 'in many countries the lack 
of financial resources was constraining the full implementation of the Plan' and that there 
is a 'need for more coordination between stakeholders within countries and the need for 
more attention to the activities of stakeholders' (paragraph 3, page 1).  
 
Relationship with other instruments 
There are very close linkages between the GPA and the IT-PGRFA. Article 14 of the IT-
PGRFA recommends that Contracting Parties 'should promote (the GPA's) effective im-
plementation, including through national actions and, as appropriate, international 
cooperation to provide a coherent framework, for capacity-building, technology transfer 
and exchange of information, taking into account the provisions of Article 13', and in arti-
cle 13.2, the Contracting Parties agree that 'benefits… shall be shared fairly and equitably 
through the following mechanisms: the exchange of information, access to and transfer of 
technology, capacity-building, and the sharing of the benefits arising from commercialisa-
tion, taking into account the priority activity areas in the rolling Global Plan of Action…'. 
The mutually supportive nature of these two agreements implies that activities under one 
will generally contribute to the implementation of the other - and thereby also to the im-
plementation of the CBD. 
 
 
2.3 The International Treaty on Plant Genetic Resources for Food and Agriculture 
(IT-PGRFA) 
 
The International Treaty on Plant Genetic Resources for Food and Agriculture (IT-
PGRFA) concluded in 2001, is the result of negotiations to revise the previous Interna-
tional Undertaking (IU) on Plant Genetic Resources. Born in 1983, the non-binding IU was 
the first comprehensive international agreement dealing with plant genetic resources for 
food and agriculture. The IU recognized that 'plant genetic resources are a heritage of 
mankind to be preserved, and to be freely available for use, for the benefit of present and 
future generations' (preamble). The IU thus promoted the free international exchange of 
these resources. With the entry into force of the CBD in 1993, there was a need to revise 
the IU to bring it into harmony with this new agreement (FAO Commission on Genetic 
Resources for Food and Agriculture - CGRFA Resolution 7/93), resulting in the IT-
PGRFA.  
 The objectives of the IT-PGRFA are the 'conservation and sustainable use of plant 
genetic resources for food and agriculture and the fair and equitable sharing of the benefits 
arising out of their use, in harmony with the Convention on Biological Diversity, for sus-
tainable agriculture and food security' (Article 1). 
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Content 
The IT-PGRFA itself applies to all plant genetic resources for food and agriculture, and a 
number of general provisions are laid out in the treaty to address the conservation and sus-
tainable use of PGRFA (articles 5 and 6). The IT-PGRFA complements the existing Global 
Plan of Action, stating that 'Contracting Parties should promote...effective implementation 
(of the GPA)' (Article 14). 
 The centrepiece of the IT-PGRFA is a multilateral system (MS) for access and bene-
fit sharing. The MS seeks to ensure that contracting parties have easier access to 
germplasm stocks for an agreed list of major crops and forages, contained in Annex 1 of 
the IT-PGRFA (see annex 4). The MS pertains to 'all plant genetic resources for food and 
agriculture listed in Annex I that are under the management and control of the Contracting 
Parties and in the public domain'1 (article 11.2). Other holders of PGRFA included in an-
nex 1 of the IT-PGRFA are invited to include such material in the MS.  
 Annex 1 of the IT-PGRFA comprises a fairly comprehensive list of most major food 
crops and a list of important forages. The list, based on 'criteria of food security and inter-
dependence' (article 11), was the subject of extensive negotiations. A number of crops did 
not find place in the final list despite a relatively high contribution to global energy intake: 
Soybean, groundnuts, sugar cane, the wild relatives of cassava included in the genus Mani-
hot, and tomato were controversial omissions (Cooper 2002). 
 For the MS, no distinction is made between material collected before and after the 
entry into force of either the treaty or the CBD. 
 The IT-PGRFA also addresses the important collections held 'in trust' by the Interna-
tional Agricultural Research Centres (IARCs) of the Consultative Group on International 
Agricultural Research (CGIAR).2 
 With the entry into force of the IT-PGRFA, there will effectively be three different 
groups of accessions or crop varieties within the public domain according to the terms of 
international access and exchange: 
 
1. the MS (or available under effectively similar conditions):  
- varieties and ex situ accessions of crops included in the MS (annex 1 of the IT-
PGRFA) and under the public domain (including IARC collections) 
- to this may be added ex situ accessions of crops not included in the MS, held 
by IARCs and received before the entry into force of the IT-PGRFA (essen-
tially all of the relevant IARC collections) 
2. subject to the CBD's Bonn Guidelines: 
- ex situ accessions of crops not included in the MS, collected after the entry into 
force of the CBD3 (or if held by an IARC, collected after entry into force of the 
IT-PGRFA) 
                                                     
1 It should be noted that the treaty does not define the scope of the public domain. The simplest interpretation 
consists essentially of what is held in public, or publically-financed, genebanks. A more comprehensive defi-
nition of this term is to define all genetic resources that are not subject to intellectual property rights as under 
the public domain (Tvedt 2002). Distinctions can also be made between the physical resource and the genetic 
information embodied in that resource such as DNA, gene and genotype information (Correa 1994). Further 
precision of this term may be an issue to be resolved by the Governing Body of the IT-PGRFA. 
2 IARC refers here exclusively to research centres of the CGIAR. 
3 29 December 1993 
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3. those with unclear status concerning access/exchange: 
- ex situ accessions of varieties of crops not included in the MS, collected before 
the entry into force of the CBD (excluding such accessions held in an IARC)  
 
Table 2.1 relates the status of germplasm in the public domain to the nature of the collec-
tion. As can be seen, the situation of the IARC collections introduces some complications 
into this typology. The vast majority of IARC collections consist of Annex 1 crops and 
these come under the MS. There are also collections held by IARCs of crops not listed in 
Annex 1, in particular soybeans, groundnuts and most species of tropical forages (Fowler 
et al 2003). According to the IT-PGRFA, these existing collections will be made available 
according to terms that will be similar to those for the MS. Thus such accessions, but not 
their respective species, can be seen as falling effectively under the MS. This provision re-
flects also the fact that IARC collections are held 'in trust' for the benefit of the 
international community according to a 1994 Agreement between the IARCs and the FAO, 
pending the conclusion of the negotiations for the IT-PGRFA. Fowler et al (2003) point 
out though that these collections risk being 'frozen in time' as provisions of the CBD will 
apply to any further accessions collected after the entry into force of the IT-PGRFA, poten-
tially inhibiting further collection and research activities.  
 As noted above, the legal status of non-Annex 1 species and material collected pre-
CBD that falls under public domain (and not held in an IARC) is still unclear in the sense 
that it is not covered by an international agreement. In principle, the relevant governmental 
authorities may determine themselves the conditions for access and benefit sharing. Coun-
tries whose governments negotiated in favour of a broad list of crops for the Multilateral 
System might be expected to maintain similar terms of access for such material. 
 Facilitated access to 'Annex 1' crops and forages is to be provided pursuant to a stan-
dard material transfer agreement (MTA), 'as well as the benefit-sharing provisions set forth 
in Article 13.2d(ii) and other relevant provisions of this Treaty' (article 12.4). In addition, 
the conditions of the original MTA should be applied to any subsequent transfers of the 
material. Material 'shall be provided solely for the purpose of utilization and conservation 
for research, breeding and training for food and agriculture, provided that such purpose 
does not include chemical, pharmaceutical and/or other non-food/feed industrial uses…' 
(Article 12.3(a) of the IT-PGRFA). 
 Limitations are placed on claiming any new intellectual property rights on material 
received from the MS: 
 
'Recipients shall not claim any intellectual property or other rights that limit the fa-
cilitated access to the plant genetic resources for food and agriculture, or their 
genetic parts or components, in the form received from the Multilateral System; (Ar-
ticle 12.3(d)).' 
 
The term 'components' will still require further interpretation and definition. Fowler et al 
(2003) suggest that the interpretation of 'in the form received' involves equally controver-
sial issues as some countries had contradictory opinions during the negotiations as to 
whether this precluded (utility) patenting of isolated, purified genes as is possible in the 
U.S. Note that recipients will be able to claim IPRs (patents and plant breeder's rights as 
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permitted by national legislation) on derivatives of the received material i.e. on new varie-
ties or inventions which incorporate the received material. 1 
 
 
Table 2.1: International legal status of plant genetic resources in the public domain 
 
 
 Crop species included  Crop species not in Multilateral System (MS)1 
 in Multi-lateral System 
 (Annex 1)1  Held in IARC2  Not held in IARC2 
  –––––––––––––––––––––––––– ––––––––––––––––––––––– 
  collected  collected collected  collected 
  pre-IT-  post-IT pre- post 
  PGRFA3 -PGRFA3 CBD4 -CBD4 
 –––––––––––––––––––– ––––––––––– –––––––––––– –––––––––– ––––––––– 
Legal  Multilateral System  Effectively  Bonn  Not clear Bonn 
Status5  MTA  Multi-  Guidelines  Guide 
  lateral   lines 
  System6 
 
 
Notes 
1. Crops included in the MS are listed in Annex I of the IT-PGRFA. 
2. International Agricultural Research Centre of the Consultative Group on International Agricultural 
Research (CGIAR). 
3. The IT-PGRFA will come into force once 40 countries have ratified it. 
4. The CBD came into force 29 December 1993. Note though that for public collections in countries that 
have not signed the CBD, all relevant material would not have any there is no distinction the U.S.A. is 
an example of a country that has not signed the CBD. This meaning that the international legal status 
of accessions held exclusively in public collections in the U.S. is also technically unclear. The U.S. 
has though signed the IT-PGRFA and it would therefore seem consistent for authorities responsible 
for public collections to follow a strategy of relatively easy access. 
5. Refers to internationally agreed terms for international exchange (access and benefit-sharing). 
6. Article 15.1(b) of the IT-PGRFA states that plant genetic resources 'other than those listed in Annex 
I...and collected before its entry into force that are held by the IARCs shall be made available in ac-
cordance with the provisions of the MTA currently in use…. This MTA shall be amended…in 
accordance with the relevant provisions of this Treaty, especially Articles 12 and 13….' This amounts 
to these resources effectively being included within the Multilateral System with respect to access and 
benefit-sharing provisions.  
 
 
 Farmers' Rights was another issue that resulted in a controversial compromise (Coo-
per 2002). The IT-PGRFA recognizes the basis for Farmers' Rights in 
 
'…the enormous contribution that the local and indigenous communities and farmers 
of all regions of the world, particularly those in the centers of origin and crop diver-
sity, have made and will continue to make for the conservation and development of 
plant genetic resources which constitute the basis of food and agriculture production 
throughout the world (Article 9.1).' 
                                                     
1 For a fuller description of key concepts and definitions see Annex 1 
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'…and agrees that 'in accordance with their needs and priorities, each Contracting Party 
should, as appropriate, and subject to its national legislation, take measures to protect and 
promote Farmers' Rights, including: 
- protection of traditional knowledge relevant to plant genetic resources for food 
and agriculture; 
- the right to equitably participate in sharing benefits arising from the utilization 
of plant genetic resources for food and agriculture; and 
- the right to participate in making decisions, at the national level, on matters re-
lated to the conservation and sustainable use of plant genetic resources for food 
and agriculture' (Article 9.1).' 
 
 The responsibility for implementing Farmers' Rights, however, lies with national 
governments. The IT-PGRFA does not recognise any rights, for example, to save, use, ex-
change or sell farm-saved seed. Rather the basis for Farmers' Rights is reflected in the 
essentially international provisions for benefit sharing and finance. Article 13.3 of the IT-
PGRFA notes that benefits 'should flow primarily, directly and indirectly, to farmers in all 
countries, especially in developing countries, and countries with economies in transition, 
who conserve and sustainable utilize plant genetic resources for food and agriculture.' 
 
Benefit sharing under the IT-PGRFA 
Benefit sharing in the MS is addressed in Article 13 of the IT-PGRFA. Benefits are to be 
shared at a general level through information exchange, access to and transfer of technol-
ogy, capacity building and the sharing of monetary and other benefits of 
commercialisation. With respect to commercialisation, the IT-PGRFA states that  
 
'the standard Material Transfer Agreement … shall include a requirement that a re-
cipient who commercializes a product … that incorporates material accessed from 
the Multilateral System, shall pay to the (financial) mechanism … an equitable share 
of the benefits arising from the commercialisation of that product, except whenever 
such a product is available without restriction to others for further research and 
breeding, in which case the recipient who commercializes shall be encouraged to 
make such payment (Article 13.2 d (ii))' 
 
This means that if the product is protected by a patent and thus restricted from further use 
in commercial breeding for example, then a payment to the financial mechanism is re-
quired. On the other hand, if the product consists of a plant variety that is protected only 
with a plant breeder's right, then such a payment will only be encouraged.1  
 The financial mechanism referred to in the IT-PGRFA is to be established by the 
Governing Body (Article 19). The level, form and manner of the payment are to be deter-
mined by the Governing Body at its first meeting, 'in line with commercial practice' 
(Article 13.2 d (ii). According to Article 13.2 d (ii), the Governing Body may also  
 
                                                     
1 Provided the Breeder's Exemption applies; see Sections 2.6 and 2.8. 
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'decide to establish different levels of payment for various categories of recipients 
who commercialize such products; it may also decide on the need to exempt from 
such payments small farmers in developing countries and in countries with econo-
mies in transition. The Governing Body may, from time to time, review the levels of 
payment with a view to achieving fair and equitable sharing of benefits, and it may 
also assess, within a period of five years from the entry into force of this Treaty, 
whether the mandatory payment requirement in the MTA shall apply also in cases 
where such commercialized products are available without restriction to others for 
further research and breeding.' 
 
 Some observers expect that the number of instances of monetary benefit-sharing un-
der the IT-PGRFA may initially be limited, given the time to develop new varieties as well 
as the fact that many potential users have their own PGRFA collections (Cooper 2002). 
 According to Article 15.1 (b) (iii), 'benefits arising under the…MTA that accrue to 
the mechanism shall be applied, in particular, to the conservation and sustainable use of the 
plant genetic resources for food and agriculture in question, particularly in national and re-
gional programs in developing countries and countries with economies in transition, 
especially in centers of diversity and the least developed countries'. As mentioned in sec-
tion 1.2, the closely linked objectives of the IT-PGRFA and the GPA mean that activities 
carried out in this context should also contribute to the implementation of the GPA. 
 Benefit sharing is a controversial issue. Identifying an appropriate level, manner and 
form of benefit sharing in the context of the IT-PGRFA will present one of the main chal-
lenges to the Governing Body at its first meeting. 
 
Implementation 
The IT-PGRFA will enter into force on the ninetieth day after the deposit of the fortieth in-
strument of ratification, acceptance, approval or accession. As of 10 December 2002, 78 
states had signed (including the Netherlands and the European Community) and eleven had 
ratified, accepted, approved or acceded to the IT-PGRFA.1 The CGRFA will act as the In-
terim Committee for the IT-PGRFA, until it enters into force. 
 As mentioned above, a Governing Body will promote the implementation of the IT-
PGRFA (see box). The Governing Body will be composed of all Contracting Parties, who 
will each have one vote. All decisions of the Governing Body shall be taken by consensus 
'unless by consensus another method of arriving at a decision on certain measures is 
reached'.  
                                                     
1 Source: FAO legal website at www.fao.org/Legal/TREATIES/033s-e.htm 
  
 31
 
Box 2: The Governing Body of the IT-PGRFA 
 
While the establishment of the International Treaty can be seen as a major achievement, many issues sur-
rounding its implementation will still need to be resolved by the Governing Body. Article 19.3 notes that 'the 
functions of the Governing Body shall be to promote the full implementation of this Treaty, keeping in view 
its objectives'. Particular tasks of the Governing Body will include 
 
- Guiding implementation: This will include providing policy direction and guidance and adopting 
plans and programmes for the implementation of the IT-PGRFA and the MS. The Governing body 
will also be responsible for establishing any necessary subsidiary bodies and adopting any required 
amendments to annexes to the IT-PGRFA 
- Establishing financial procedures: The Governing Body will be responsible for adopting and peri-
odically reviewing the funding strategy for the implementation of the IT-PGRFA, including the level, 
form and manner of payments to be made to the financial mechanism under the MS, and the budget 
for the IT-PGRFA. It may also need to establish an appropriate mechanism, such as a Trust Account, 
for receiving and utilizing financial resources. 
- Cooperating with relevant international organisations: The Governing Body will be responsible 
for maintaining the relationship with the CBD, and other relevant international organizations and 
treaty bodies, and for approving the terms of agreements with the IARCs and other international insti-
tutions.  
- Adopting a Standard MTA: Last but certainly not least, the Governing Body will be responsible for 
adopting a standard MTA for the MS. 
 
 
2.4 The Agreement on Trade-Related Aspects of Intellectual Property Rights 
(TRIPS) 
 
The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) is one of 
the agreements adopted in 1994 at the close of the Uruguay Round of negotiations under 
the General Agreement on Tariffs and Trade (GATT). It came into force in 1995 under the 
umbrella agreement establishing the WTO.  
 TRIPS and other WTO agreements are binding upon the 131 countries that are mem-
bers of the WTO, with strong incentives for compliance including a dispute-settlement 
mechanism that provides for the imposition of trade sanctions (including sanctions on trade 
in unrelated products) against a Member found in violation of the Agreement. 
 
Content 
The TRIPS Agreement encompasses all forms of intellectual property and aims at harmo-
nizing and strengthening standards of protection and providing for effective enforcement at 
both national and international levels. Important provisions include that of national treat-
ment: property rights conferred at a national level must apply to nationals of all WTO 
member states. In addition, any advantage, privilege or immunity granted to a national of 
any other country must be accorded immediately and unconditionally to the nationals of all 
WTO members (most-favored-nation treatment). 
 Standards that are particularly important for PGRFA are found in Article 27 of 
TRIPS. Paragraph 1 requires that, subject to the provisions of paragraphs 2 and 3, 'patents 
shall be available for any inventions, whether products or processes, in all fields of tech-
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nology, provided that they are new, involve an inventive step and are capable of industrial 
application'. Article 27.3(b) of the TRIPS agreement allows Members to exclude from pat-
ent ability 'plants and animals other than micro-organisms, and essentially biological 
processes for the production of plants or animals other than non-biological and microbi-
ological processes', however they are obliged to provide some form of intellectual property 
protection of plant varieties, 'either by patents or by an effective sui generis system or by 
any combination thereof'.1  
 TRIPS currently allow considerable flexibility in the protection afforded to plant va-
rieties. No specific requirements for a sui generis system are set down in the TRIPS 
Agreement other than that it be 'effective' (in protecting intellectual property). The Interna-
tional Union for the Protection of New Varieties of Plants (UPOV) is one existing 
international sui generis system that can fulfil this requirement, and a number of develop-
ing countries have reacted to these stipulations by signing one or other of the two valid 
versions of the UPOV Convention (UPOV 1978 and UPOV 1991; see Section 2.6 of this 
report). The UPOV Convention is designed to serve the needs of commercial seed breed-
ers; however, for many developing countries, issues such as Farmers' Rights are 
insufficiently addressed by the UPOV convention and they have opted for the development 
of a national or regional sui generis system (e.g. the Indian Act No. 123 of 1999 for the 
protection of plant varieties and Farmers' Rights, which is enacted but not yet in force). On 
the other hand, in the United States, both (utility) patents and plant varietal protection are 
available for plant varieties.2  
 
Implementation 
The operation of the TRIPS Agreement and Members' compliance with its terms is moni-
tored by the TRIPS Council, based in Geneva. The Council provides Members with a 
forum for consulting on TRIPS issues, and provides assistance to members as requested in-
cluding assistance regarding dispute settlement. It is one of a number of institutions for 
monitoring implementation of WTO agreements, modifying or interpreting them if needed, 
negotiating new trade agreements and resolving disputes under existing ones. The Council 
generally meets formally four times a year, and also holds several informal sessions. Inter-
governmental agencies may attend Council sessions, but NGOs may not (Bragdon and 
Downs 1998). 
 It was agreed that Article 27.3(b), was to be reviewed 'four years after the date of en-
try into force of the WTO Agreement.' The review of Article 27.3(b) began in 1999. At the 
Fourth World Trade Organization (WTO) Ministerial Conference held in Doha, Qatar in 
November 2001, the WTO Members agreed to launch a new round of multilateral trade 
negotiations that will have important implications for agriculture, fisheries and forestry. A 
substantial work program was agreed in the area of environment and trade, and the new 
round will also include a revision of TRIPS, in particular article 27.3 (b) on patentability of 
plant and animal inventions, and the protection of plant varieties.  
 The Doha Declaration also states that work in the TRIPS Council on these reviews or 
any other implementation issue should also look at: the relationship between the TRIPS 
                                                     
1 See annex 1 on key terms 
2 Vegetatively-propagated plant species are eligible for a third category of protection, plant patents, in the 
United States. 
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Agreement and the UN Convention on Biological Diversity; the protection of traditional 
knowledge and folklore; and other relevant new developments that member governments 
raise in the review of the TRIPS Agreement. The deadline for negotiations specifically 
mandated in Doha Declaration is the 1 January 2005. 
 
 
2.5 The World Intellectual Property Organization (WIPO) 
 
WIPO is a UN specialized agency that administers 23 international treaties dealing with 
different aspects of intellectual property protection and reviews the suitability of existing 
instruments for the protection of property rights (i.e. patents, variety protection, copyrights, 
trade secrets etc.). In general, WIPO serves to promote international harmonisation of in-
tellectual property systems, to facilitate information exchange and to support developing 
countries developing IP systems. WIPO currently has 179 member states1. 
 With respect to PGRFA, WIPO is undertaking a number of activities with the Inter-
national Union for the Protection of New Varieties of Plants (UPOV), aimed at clarifying 
the relationship between protection for plant varieties and patent protection for biotechno-
logical inventions (see Sections 2.7 and 2.8).  
 WIPO is investigating, in collaboration with other international bodies, possibilities 
for the protection of the property rights of indigenous and traditional communities, when 
their knowledge and innovations are commercialized and marketed. This includes studying 
whether specific instruments of property rights protection (sui generis) need developing, if 
the indigenous peoples' requirements for protection cannot be met through the implementa-
tion of the established instruments. At WIPO's 26th General Assembly (September-
October 2000), member states decided to establish a special body to discuss intellectual 
property issues related to genetic resources, traditional knowledge and folklore. This body, 
the Intergovernmental Committee on Intellectual Property and Genetic Resources, Tradi-
tional Knowledge and Folklore, held its first session in Geneva, April-May 2001.  
 The work of WIPO is in line with the work of the CBD on traditional knowledge. An 
echo is found in the CBD-COP decision V/16 on Article 8(j) and related provisions, which 
 
'Recognizes the potential importance of sui generis and other appropriate systems for 
the protection of traditional knowledge of indigenous and local communities and the 
equitable sharing of benefits arising from its use, to meet the provisions of the Con-
vention on Biological Diversity, taking into account the ongoing work on Article 8(j) 
and related provisions, and transmits its findings to the World Trade Organization 
and the World Intellectual Property Organization' 
 
 In addition, as mentioned in section 1.1, The COP-CBD recently invited WIPO to 
prepare a technical study on the potential for disclosure of information relating to genetic 
resources within patent applications. 
 
 
                                                     
1 Source: WIPO website at www.wipo.org 
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2.6 Plant Breeders' Rights and the UPOV Convention 
 
The International Union for the Protection of New Varieties of Plants (UPOV) came into 
existence in 1961. Under the UPOV Convention, member states acknowledge the accom-
plishments of breeders of new plant varieties by making available to them exclusive rights 
of exploitation. The UPOV Convention was revised in 1972, 1978 and 1991. The 1961 Act 
of the Convention entered into force in 1968, the Additional Act of 1972 in 1977, the 1978 
Act in 1981, and the 1991 Act on 24 April 1998. As of July 2003, UPOV comprised 53 
members, mostly from industrialised countries. 
 UPOV provides for the granting of the Plant Breeder's Right (PBR) where 'the vari-
ety is new, distinct, uniform and stable', which in the 1991 Act mean that the following 
acts in respect of the propagating material of the protected variety require the authorization 
of the breeder (Article 14: Scope of the Breeder's Right): 
- production or reproduction (multiplication);  
- conditioning for the purpose of propagation;  
- offering for sale; 
- selling or other marketing; 
- exporting; 
- importing; 
- stocking for any of the purposes mentioned in (i) to (vi), above. 
 
 The breeder may also make his authorization subject to conditions and limitations. In 
the 1978 Act, prior authorization of the breeder is required only for purposes of commer-
cial marketing, offering for sale, or marketing of the reproductive or vegetative 
propagating material of the variety.  
 The 1978 Act allowed farmers to use protected varieties fairly freely for cultivation, 
known as the 'farmers' privilege'. The Act of 1991 restricted this privilege to an optional 
exception to the breeder's right that allows Contracting Parties to 
 
'…within reasonable limits and subject to the safeguarding of the legitimate interests 
of the breeder, restrict the breeder's right in relation to any variety in order to permit 
farmers to use for propagating purposes, on their own holdings, the product of the 
harvest which they have obtained by planting, on their own holdings, the protected 
variety…' 
 
Although the 1991 Act does not include the above 'farmers' privilege', it still maintains a 
restriction on PBRs: private, non-commercial and experimental acts are allowed, as well as 
for acts done for the purpose of breeding other varieties (known as the 'breeder's exemp-
tion'). Developing countries that have signed the UPOV Convention have generally opted 
for the less restrictive 1978 Act.  
 Like other forms of intellectual property rights, the breeder's right is granted for a 
limited period of time, at the end of which protected varieties pass into the public domain. 
 UPOV works in close contact with the World Intellectual Property Organization of 
the United Nations (WIPO), with which it has concluded a cooperation agreement. The Of-
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fice of UPOV is under the direction of a Secretary-General who is, by agreement between 
UPOV and WIPO, is the Director-General of WIPO. 
 
 
2.7 EU Directive on patenting of biotechnological inventions  
 
The TRIPS Agreement requires that WTO member states offer patent protection for bio-
technological inventions relating to other biological material and microbiological 
processes. In the European Union, EC Directive 98/44/EC, adopted in July 1998 obliges 
member states to offer such patent protection. 
 The Directive determines that plant and animal varieties are not patentable (as is al-
lowable under TRIPS). To be eligible for protection, an invention, which concerns plants 
or animals, must not be technically confined to a single plant or animal variety. 
 According to the Directive, member states are required to offer patent protection for 
inventions that consist of 'biological material, which is isolated from its natural environ-
ment or produced by means of a technical process….' (Art 3, para 2). The Directive thus 
provides for the patenting of the isolation of (partial) sequences of genes contained in a 
plant variety provided the industrial application is disclosed and, as stated above, that this 
application is not confined to only that plant or animal variety.  
 Furthermore, Directive 98/44/EC indicates that a patent application for an invention 
that is based on plant or animal biological material should include information on the geo-
graphical origin of such material, if known, although this is without prejudice to the 
processing of patent applications. In 2002, the EC issued a communication to the TRIPS 
council in which it proposed that disclosure of origin was desirable but should not be for-
mally required within patent law. This potentially avoids conflicts with TRIPS while 
ensuring that a means of monitoring compliance with the conditions on patentability stipu-
lated for receivers of material from the Multilateral System of Facilitated Access and 
Benefit-Sharing (see section 1.6). 
 Regarding the relationship with TRIPS and the CBD, the Directive states (article 1 
para 2) that 'this Directive shall be without prejudice to the obligations of the Member 
States pursuant to international agreements, and in particular the TRIPs Agreement and the 
Convention on Biological Diversity'. It also notes that the European Community is party to 
the Convention on Biological Diversity and that '…Member States must give particular 
weight to Article 3 (on national sovereignty) and Article 8(j) (on traditional knowledge), 
the second sentence of Article 16(2)1 and Article 16(5)2 of the Convention when bringing 
into force the laws, regulations and administrative provisions necessary to comply with this 
Directive'. The Directive further notes the observation in CBD Decision III/17 that 'further 
work is required to help develop a common appreciation of the relationship between intel-
                                                     
1 'In the case of technology subject to patents and other intellectual property rights, such access and transfer 
shall be provided on terms which recognize and are consistent with the adequate and effective protection of 
intellectual property rights'(Article 16.2 of the CBD, second sentence) 
2 'The Contracting Parties, recognizing that patents and other intellectual property rights may have an influ-
ence on the implementation of this Convention, shall cooperate in this regard subject to national legislation 
and international law in order to ensure that such rights are supportive of and do not run counter to its objec-
tives' (Article 16.5 of the CBD) 
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lectual property rights and the relevant provisions of the TRIPs Agreement and the Con-
vention on Biological Diversity'. 
 
 
2.8 The relationship between the agreements 
 
Historical developments 
The international agreements relating to agricultural plant genetic resources were devel-
oped at different periods in time. The history of these agreements (represented in the 
timeline contained in Annex 2) reflects the evolution of various policy and management is-
sues of major concern. These issues may be summarised as: 
- Conserving plant genetic resources; 
- Ensuring access to and use of plant genetic resources, particularly for breeding ef-
forts (for all stakeholders, in the North and in the South); 
- Distribution of the benefits arising from the use of plant genetic resources amongst a 
range of stakeholders (especially states, seed breeders, farmers, and rural communi-
ties).  
 
 The various international instruments have focused on different aspects of these is-
sues. To address these issues, the various agreements have created or recognised certain 
property rights over agricultural genetic resources for different stakeholders.  
 The UPOV Convention (1961), which can be seen as an attempt to harmonise al-
ready existant national level PVP systems, addresses the use of plant genetic resources for 
commercial breeding purposes and the distribution of the resulting benefits. UPOV thus 
harmonised (intellectual) property rights granted (under national jurisidiction) to seed 
breeders for the development of new plant varieties. These exclusive exploitation rights 
were meant to ensure that the seed breeders would be allocated enough of the benefits from 
their varieties to make their activities commercially viable. 
 The non-binding FAO International Undertaking (1983), negotiated by ministries of 
agriculture, focused on both the conservation and use of existing genetic resources, such as 
landraces, for formal sector seed breeding. The IU promoted the perspective that these ge-
netic resources be considered as a form of international common property. These were to 
be conserved (using public resources) and made available for both public and private sec-
tor stakeholders for the purposes of breeding new varieties. There is a clear parallel and 
consistency between the availability of these common property resources and the breeder's 
exemption provision of UPOV which ensures that new varieties are also freely available 
for yet further breeding efforts. 
 The CBD (1993) focuses on the conservation of genetic resources and the distribu-
tion of the benefits arising from their use. The management, including conservation, of 
genetic resources (particularly non-agricultural forms of biological diversity) has been 
largely a public task; the rationale of the CBD is thus to support that task by alterring the 
distribution of benefits from the use of genetic resources. The CBD formally recognises all 
genetic resources as a form of national public property (national sovereignty). By regulat-
ing and controlling access to these resources, states are intended to be able to capture an 
'equitable' share of the benefits from their use by stakeholders in other countries. But these 
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rights are not retroactive, applying only to the collection and exchange of resources after 
the entry into force of the CBD.1 For agricultural plant genetic resources, the legal status of 
many (but not all) genetic resources collected and exchanged prior to the CBD has been 
clarified by the IT-PGRFA.  
 The IT-PGRFA (2001) is the outcome of a negotiation process to revise the IU and to 
bring it in line with the CBD. The IT-PGRFA thus also adresses the conservation and use 
of genetic resources. The IT-PGRFA, as a legally binding treaty, recognises a large group 
of these genetic resources (the Multilateral System for crops listed under its Annex 1) ef-
fectively as a form of international public common property.2 In so doing, the IT-PGRFA 
can be seen as promoting the use of these genetic resources for further breeding efforts. 
The IT-PGRFA also addresses the distribution of the benefits arising from this use with its 
benefit-sharing provisions. As seen above, these place additional obligations for benefit-
sharing on seed breeders who restrict the availability of their resulting innovations for fur-
ther research with for example patent protection where possible. The IT-PGRFA also 
recognises another group of genetic resources as being national common property and thus 
falling under the CBD. 
 Parallel to the development of the CBD, the TRIPS Agreement was negotiated from 
a trade perspective within the framework of the GATT-WTO. Like UPOV, the TRIPS 
Agreement also addresses the use of genetic resources for developing new varieties and the 
distribution of the resulting benefits. In effect, the TRIPS Agreement ensures the estab-
lishment of (intellectual) property rights over new plant varieties in all WTO member 
countries. While UPOV is only one possible option for the creation of these rights, the type 
of property right to be established is similar in essence, if not necessarily in scope.3 Per-
haps equally important, TRIPS also establishes intellectual property rights, in the form of 
patents, for all technological inventions. As a result, more and more countries are obliged 
to offer patent protection for biotechnological inventions, including those in the field of ag-
riculture. While states may ensure that this excludes plants from patentability, overlapping 
rights may be introduced where patent protection is offered to biotechnological inventions 
that are then embodied in new plant varieties. This issue is addressed below. 
 Thus, in principle, the various agreements are largely complimentary. The IT-
PGRFA and the CBD recognise the common property nature, whether national or interna-
tional, of existing plant varieties and establish conditions for their international exchange 
for use in breeding efforts. UPOV and the TRIPS Agreement have allowed the creation of 
(intellectual) property rights, to be held by individual stakeholders such as companies, in-
stitutes and individuals, over newly created varieties. Uncertainties remain though as to the 
terms for access and exchange to some plant genetic resources, as reviewed in Section 2.3. 
Furthermore, the manner in which governments implement legislation to respect the condi-
tions placed on the use of genetic resources by the IT-PGRFA and the CBD needs to take 
into account provisions of the TRIPS Agreement, and possibly UPOV. These areas are also 
discussed below. 
 
                                                     
1 29 December 1993. 
2 Although the principle of national sovereignty still holds. 
3 The minimum form of intellectual property protection necessary under a sui generis system has yet to be 
defined or agreed upon within TRIPS. 
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Patents and Plant Variety Protection 
The implementation of patents for biotechnological inventions and plant variety protection 
as required under TRIPs can lead to overlapping forms of protection. In particular, a new 
plant variety may also embody an invention, most likely in the form of a genetically engi-
neered component (gene or genetic sequence) that is covered by patent protection. An 
important question is then whether the patent implies any restriction on the use of the vari-
ety for further commercial breeding purposes. Any such restriction would then not be 
consistent with the breeder's exemption provision of PVP (UPOV) legislation. 
 In general, the scope of either the patent or the plant breeder's right has to be limited 
if this issue is to be clarified. The patent can take precedence implying either a restriction 
of the breeder's exemption. Or, with appropriate legislation, the breeder's exemption could 
be given precedence implying a restriction on the normal scope of patents. Such a restric-
tion may possibly be allowable under TRIPS by referring to Article 30 (Jordens 2002). A 
restriction to the breeder's exemption due to the scope of patents, on the other hand, is not 
likely to require any specific legislation. 
 The EC Directive 98/44/EC has addressed this issue (in Article 12) by obliging 
Member States to offer plant breeders the opportunity to apply for compulsory licences for 
use of the patented invention, including the payment of an 'appropriate royalty'. Applicants 
for such compulsory licences must demonstrate that they have not been able to negotiate a 
contractual licence and the plant variety under development 'constitutes significant techni-
cal progress of considerable economic interest compared with the invention claimed in the 
patent.' It can be argued that these conditions are not only vague but that the demands 
placed on plant breeders are rather onerous. Plant breeding typically involves many years 
before a potentially successful variety is developed. It is thus difficult to demonstrate the 
economic and technical value of the end product at the beginning of this period when a 
compulsory licence might be required (Jordens 2002). 
 WIPO and UPOV look for clarification on the interaction between patents and plant 
variety protection. The organisations therefore organised a joint symposium on this issue in 
October 2002.1 UPOV in particular has recognised that the assured maintenance of the 
breeder's exemption is one of the defining characteristics of plant variety protection, as dis-
tinct from patents. 
 
Protection and Benefit Sharing of Material falling under the CBD or the Multilateral Sys-
tem 
Under both the CBD and the IT-PGRFA, restrictions and conditions will be placed on the 
receiver of genetic material with respect to intellectual property protection that may be 
sought by the receiver as well as ensuing financial obligations. Genetic resources that fall 
under the CBD are essentially national property and a foreign receiver of these resources 
                                                     
1 This symposium also dealt with the issue of essentially derived varieties (EDV) which, under UPOV 1991 
effectively extends the breeder's right to cover newly bred varieties that only differ from an existing protected 
variety by the insertion of a genetic element. Depending on national patent legislation, the new variety may 
effectively fall under the scope of patent protection afforded to the contained invention. UPOV 1991 ensures 
that the rights of the breeder of the first variety are still respected. For countries that adhere to the 1978 
UPOV Act or other sui generis forms of protection, the issue of how to deal with EDVs still exist although it 
can be ignored. 
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may only apply for intellectual property protection on these resources or any derivative 
thereof provided that terms for so doing have been agreed with the originating country. 
Recipients of genetic resources from the Multilateral System are bound to refrain from 
claiming intellectual property rights on these resources, or their genetic parts or compo-
nents.1 Furthermore such recipients must also contractually require the same from any 
further parties to whom they make the same materials available. In addition, recipients of 
material from the Multilateral System who then incorporate this material into a commer-
cialised product (e.g. a new plant variety) are obligated to pay a share of the resulting 
benefits to the financial mechanism to be established within the framework of the IT-
PGRFA. 
 The issue is to what extent these conditions and provisions place obligations on gov-
ernments. The Bonn Guidelines of the CBD requires countries to take 'appropriate legal, 
administrative, or policy measures to support compliance with PIC and MAT.' The range 
of available options is thus quite broad ranging from legislation to simple policies that lack 
effective implementation measures. With respect to the IT-PGRFA, it has been suggested 
that governments may be obliged to amend their IPR laws so as to deny the possibility of 
protection being sought and granted for material originating from the Multilateral System 
or for which PIC and MAT have not been obtained (Hefler 2002). But the IT-PGRFA 
states that obligations in the MTAs pertain to the parties to the MTAs and that govern-
ments are obliged to ensure that opportunities are available for these parties to seek judicial 
recourse. This can be seen as precluding the need for amendments to IPR legislation as 
long as providers of genetic material have the ability to enforce the terms of their MTAs 
(or eventually MAT) under contract law. 
 Avoiding any amendments to IPR legislation concerning fulfillment of conditions 
regarding MTAs or MATs is advantageous because of the possible conflicts between such 
amendments and TRIPS. Article 29 (Conditions on Patent Applications) of TRIPS restricts 
the imposition of additional conditions on the granting of protection. 
 Amendments relating to benefit sharing in IPR legislation, specifically in the case of 
patented products derived (in part) from material received from the Multilateral System, 
may be less problematic. Hefler (2002) indicates that TRIPS does not prohibit the imposi-
tion of fees and levies associated with the holding of patent rights, although it is not clear 
that allowing such fees to vary (i.e. to be higher for the types of patents in question) would 
be TRIPS compliant. 
 There is a logical precedent for not amending IPR legislation on these points and 
leaving enforcement of conditions contained in MTAs (and MAT) to the parties concerned. 
Current patent and plant variety protection systems must also deal with possibilities of 
wrongful applications to seek protection for material for which rights for exploitation are 
already defined (e.g. existing plant varieties), potentially under another form (e.g. public 
property). In some countries, the application review process is intended to eliminate some 
of these possibilities. Otherwise, the responsibility for contesting such claims essentially 
lies with the holder of any other conflicting rights that may be deemed to have precedence. 
 Placing the obligations of enforcing MTAs (MAT) on the providers of material raises 
however some practical problems. Most providers are stakeholders in developing countries 
                                                     
1 The separate, but related, issue of defining what 'components' are has been addressed in Section 2.3.  
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such as public genebanks, or even governments in the case of MAT for material coming 
under the CBD. Such stakeholders are generally at a serious disadvantage in comparison to 
typical recipients of material in industrialised countries (e.g. corporations) in terms of re-
sources and experience with IPR systems, including associated litigation. 
 The EC has proposed a measure that is intended to contribute to recipients of mate-
rial respecting their contractual obligations with providers. EC Directive 98/44/EC states 
that a patent application for an invention based on biological material of plant or animal 
origin should include information on the geographical origin of such material. This is not 
proposed though as a formal condition on the granting of the patent.1 The EC has made a 
similar recommendation to the TRIPS Council (EC 2002). This is thus one option for fa-
cilitating the use and enforcement of these agreements such as MTAs and MAT. A similar 
provision could be applied to PVP legislation but has received little attention presumably 
due to the fact that PVP, in contrast to patents, provides fewer restrictions on what may be 
done with the protected material.  
 In reaction, the International Seed Federation (an association representing commer-
cial seed breeders and producers) has indicated that the industry could consider providing 
information in intellectual property rights applications as to the source of biological mate-
rial (ISF 2003). This refers to where the material was obtained by the applicant, unless the 
source is no longer known (e.g. if the material has long been maintained in a breeder's own 
nursery) or if confidential contracts with the provider preclude such disclosure. The ISF 
position is that it is difficult in many cases, if not impossible, to indicate the origin of such 
biological material where the origin refers to the 'country of origin' as defined in the CBD. 
 
Conclusions 
In summary, the international agreements described above have been developed at differ-
ent times and from different perspectives. As they currently stand, outright conflicts 
between the restrictions and conditions of the CBD and the IT-PGRFA, on the one hand, 
and the requirements of TRIPS and UPOV on the other, need not arise. Avoiding such con-
flicts will depend in part on negotiations in international arenas - such as the Doha 
negotiations and specific implications for TRIPS, as well as the work of the Governing 
Body of the IT-PGRFA. It should also be emphasised that specific conflicts will eventually 
materialise at the level of national implementation. Thus avoiding conflicting legislative 
frameworks requires a proactive examination of the interaction between existing and pro-
posed implementing legislation at the national level. The approach of leaving enforcement 
of the CBD's and the IT-PGRFA's provisions on access and benefit-sharing to the realm of 
contract law will probably imply special challenges in the implementation of these agree-
ments. The legitimacy of these frameworks among a variety of stakeholders could well 
depend, in part, on how such challenges are met. 
                                                     
1 Pires de Carvalho (2000) has alternatively proposed that a disclosure requirement could be considered by 
the judiciary as a condition for enforcing protection, which would also not be in conflict with TRIPS. 
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3. Implications for Dutch genetic resources policy 
 
 
 
3.1 Introduction 
 
The Netherlands is actively involved in the development and implementation of the inter-
national instruments related to genetic resources. The Netherlands signed the Convention 
on Biological Diversity in 1992, and has adopted the CBD as a framework for national 
biodiversity policy. The Netherlands was one of the 150 countries to adopt the Leipzig 
Declaration and the FAO Global Plan of Action on Plant Genetic Resources for Food and 
Agriculture in 1996. The Netherlands is also a member of the WTO and thus a party to the 
TRIPS agreement, as well as being party to the 1991 Act of the UPOV Convention. 
 Government policy relating to agricultural genetic resources is presented in the pol-
icy document Sources of Our Existence (referred to hereafter as SoE1), which was adopted 
in 2002. Dutch government policy documents on nature management and the environment, 
Nature for People, People for Nature (NvM)2 and the 4th National Environmental Policy 
Plan (NMP4),3 are also relevant given the implications of environmental management for 
the use of genetic resources in agriculture. NvM takes the place of four previous nature 
management policy programmes including the Strategic Action Plan for Biodiversity, and 
also provides a framework for the conservation and sustainable use of biodiversity in vari-
ous sectors, including agriculture.  
 Another important document is the International Policy Programme Biodiversity 
2002-2006 (referred to hereafter as BBI)4 which indicates how a number of biodiversity-
related policy commitments, contained in the various policy documents mentioned above, 
will be implemented, concentrating on international aspects. BBI notes that ultimate solu-
tions to biodiversity loss are not clear. Policy in this evolving area is thus 'mainly 
concerned with establishing the right direction and identifying common ground.' (p. 9). 
 
According to SoE, the Netherlands is committed to: 
- Clarifying the specification of commitments under the Convention on Biological Di-
versity (CBD) and other conventions on genetic resources. This can be [formulated] 
in general CBD guidelines, which will contribute to an alignment of national policy 
and legislation; 
- Implementing the International Treaty on Plant Genetic Resources for Food and Ag-
riculture, focusing on management and utilization of the main crops in agriculture 
and food production; 
- Specifying the cohesion between the CBD and international agreements on intellec-
tual property rights, primarily as stated in WTO-TRIPS, UPOV and WIPO; 
                                                     
1 Dutch title: Bronnen van ons Bestaan. 
2 Dutch title: Natuur voor Mensen, Mensen voor Natuur. 
3 Dutch title: Nationaal Milieubeleidsplan 4. 
4 Dutch title: Internationaal Beleidsprogramma Biodiversiteit 2002-2006. 
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- Implementing policy, regulations and legislation on modern biotechnology, in par-
ticular the Cartagena Protocol on Bio safety. 
 
 Both SoE and BBI indicate that the private sector, researchers and other organisa-
tions or stakeholders will be expected to assume most of the responsibility for 
implementing of policy commitments. The government assumes some but not all responsi-
bility. The government states that it will facilitate or support implementation by others and 
emphasises the national and international exchange of expertise and information. Specific 
examples, such as the creation of an infrastructure for information exchange and the devel-
opment of codes of conduct, are discussed below as well as with respect to the relevant 
articles of the CBD and the IT-PGRFA.  
 The government has thus concluded that additional legislation on the subject of ge-
netic resources is not appropriate or necessary at this moment. Such legislation could 
conceivably entail the application of other types of policy measures, such as legal require-
ments or the use of financial mechanisms. BBI indicates at this point that the eventual need 
for such legislation will depend on progress in the application of policy and on develop-
ments in the context of international agreements such as the IT-PGRFA and the CBD, as 
well as on intellectual property issues. The development of common legislation and regula-
tions within the European Union will also be considered. 
 SoE indicates that the possibilities for implementing the policy without resorting to 
additional legislation depend on the greatest possible transparency over the management 
and use of genetic resources, care in the transaction and exchange of genetic resources, and 
the assumption by all concerned of his/her own responsibility. While not specifically indi-
cated, presumably the last of these conditions will be promoted through the development of 
codes of conduct. 
 To support the implementation of its genetic resources policy, the government is 
committed to establishing a Genetic Resources Platform, consisting of representatives from 
the business sector, research organizations, social organizations and the government. This 
platform, together with the National Information Centre for Genetic Resources (see Section 
3.2), will form the institutional infrastructure for facilitating information exchange and pre-
sumably provide a means by which the government can encourage stakeholders to respect 
national policy in their actions. This stakeholders platform will address a number of spe-
cific issues relevant to Dutch genetic resources policy, including: 
- Strengthening the economic position of The Netherlands concerning the use of ge-
netic resources, with special attention to the role and input of the private industry in 
the agro-food sector and in biotechnology; 
- Promoting the development and use of Codes of Conduct that contain the basic prin-
ciples of this policy document; 
- Promoting the development and use of Material Transfer Agreements, with which a 
prudent exchange of genetic resources can be set up; 
- Improving the exchange of knowledge and information via the National Information 
Centre for Genetic Resources, among others; 
- Reinforcing cooperation between The Netherlands and certain selected countries. 
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 Table 3.1 provides an overview of selected obligations of the Dutch government un-
der the international instruments discussed in Section 2 of this report. The following 
sections (3.2, 3.3 and 3.4) describe efforts of the Netherlands that contribute to the imple-
mentation of these international agreements, taking each one in turn. Section 3.5 provides 
some concluding remarks, including a summary of implications of international agree-
ments that are still undergoing implementation. 
 
Table 3.1 Summary of selected obligations under international agreements 
 
Agreement 
[Article] 
Obligation 
CONVENTION ON BIOLOGICAL DIVERSITY 
CBD [6] General Measures: Develop national strategies/plans/programs for biodiversity or adapt 
existing ones.  
Integrate biodiversity into (cross)sectoral strategies/plans/programs 
CBD [8] In situ conservation: protected areas; management of biodiversity in non-protected eco-
systems; controlling LMOs & alien species risks; promoting compatibility between 
conservation & sustainable use & supporting developing countries 
CBD [8 (j)] Traditional Knowledge: Respect, preserve and maintain knowledge and practices of in-
digenous and local communities, equitable sharing of the benefits arising from the 
utilization of such knowledge and practices 
CBD [9] Ex Situ Conservation: Conserve biodiversity ex situ; rehabilitate and reintroduce threat-
ened species as appropriate; Regulate and manage collection of biological resources so as 
not to threaten ecosystems or species; support developing countries 
CBD [15] Access and Benefit-sharing: Recognize national sovereignty. Facilitate access to genetic 
resources for environmentally sound uses by other Parties on mutually agreed terms 
(MAT) and subject to subject to prior informed consent (PIC) 
CBD [16] Technology Transfer: Provide/facilitate access for and transfer to other Parties of relevant 
technologies & take measures with the aim that Parties, especially developing countries, 
are provided access to and transfer of technology on mutually agreed terms including tak-
ing legislative, administrative or policy measures, as appropriate, with the aim that the 
private sector facilitates access to, joint development and transfer of technology for the 
benefit of both governmental institutions & private sector of developing countries; cooper-
ate on IPRs. 
CBD [17] Exchange of Information: Facilitate exchange of information including exchange of re-
search results, on training & surveying, specialized knowledge, indigenous & traditional 
knowledge & technologies. 
CBD [18] Technical and Scientific Co-operation: Promote international technical and scientific co-
operation, including for indigenous and traditional technologies, for biodiversity, national 
policies, and capacity building. Promote cooperation in the training of personnel and ex-
change of experts, and joint research programs 
CBD [19] Biotechnology: Biotechnological research, promote priority access to Parties to biotech. 
benefits; consider the need for and modalities of a bio safety protocol; provide information 
on safety regulations required in handling LMOs, and information on impacts 
INTERNATIONAL TREATY ON PLANT GENETIC RESOURCES FOR FOOD AND 
AGRICULTURE (IT-PGRFA) 
IT-PGRFA 
[Part II ] 
General Provisions: Conservation, Exploration, Collection, Characterization, Evaluation 
& Documentation of PGRFA (art. 5); Sustainable use (art. 6) National Commitments & in-
ternational collaboration (art.7) & technical assistance (art.8) 
IT-PGRFA 
[Part III ] 
Farmers' Rights: Take measures to protect and promote Farmers' Rights, including pro-
tection of traditional knowledge, the right to equitably participate in sharing benefits & the 
right to participate in making decisions, at national level (art. 9) 
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IT-PGRFA 
[Part IV ] 
Multilateral System of Access and Benefit-Sharing: Place annex 1 PGR in the Multilat-
eral System & encourage other holders; Facilitate access to MS PGR; Take necessary legal 
or other measures; Provide information on technology transfer & access; Contribute to ca-
pacity building for other countries 
IT-PGRFA 
[Part V ] 
Supporting Components: Promote the implementation of the GPA (art. 14); Provide fa-
cilitated access to IARCs in the MS (art. 15); Encourage institutions to participate in 
networks (art. 16); Cooperate to develop and strengthen global information system (art. 17) 
IT-PGRFA 
[Part VI ] 
Financial Provisions: Ensure resources for IT-PGRFA. Provide financial resources, in-
cluding through the financial mechanism & for national PGRFA activities  
AGREEMENT ON TRADE-RELATED ASPECTS OF INTELLECTUAL PROPERTY RIGHTS 
(TRIPS) 
TRIPS 
[27(3)b] 
IPR protection for plant varieties: Some form of intellectual property protection of plant 
varieties must be provided, 'by patents or by an effective sui generis system or by any 
combination thereof' 
TRIPS 
[27(2)] 
General exemption to patentability: Members may exclude from patentability inven-
tions, the prevention within their territory of the commercial exploitation of which is 
necessary to protect order public or morality, including to protect human, animal or plant 
life or health or to avoid serious prejudice to the environment… 
CONVENTION FOR THE PROTECTION OF NEW VARIETIES OF PLANTS (UPOV) – 1991 
ACT 
UPOV [2] Basic Obligation: Grant and protect the breeder's right 
UPOV 
[3(1)] 
Genera & Species to be Protected: Apply the provisions of this Convention…at the latest 
by the expiration of a period of five years after the said date, to all plant genera and species 
(i.e., April 2003), and prior to this to all plants and species to which the previous version 
applies. 
UPOV [5] Requirements for Protection: Breeders rights shall be granted for varieties that are new, 
distinct, uniform and stable varieties, granting shall not be subject to any further or differ-
ent conditions 
UPOV 
[14(1)] 
Scope of Breeders' Right: Authorization of the breeder required for: production or repro-
duction; conditioning for the purpose of propagation; offering for sale; selling or other 
marketing; exporting; importing; stocking for any of these purposes. Breeder may also 
make his authorization subject to conditions and limitations. 
UPOV 
[15(1)] 
Exemptions (research & breeding): Breeder's right shall not extend to private, non-
commercial and experimental acts, or acts done for the purpose of breeding other varieties. 
UPOV 
[15(2)] 
Exemptions (farm-saved seed): Contracting parties may restrict breeder's right to permit 
farmers to use for propagating purposes, on their own holdings, the product of their own 
harvest. 
EU DIRECTIVE 98/44/EC ON LEGAL PROTECTION OF BIOTECHNOLOGICAL 
INVENTIONS 
[1] Patentability biotechnological inventions: Protect biotechnological inventions under na-
tional patent law. Without prejudice to international agreements, especially TRIPS and 
CBD. 
[11] Farm-saved seed: Sale to a farmer of plant propagation material implies authorization for 
use of harvest product for propagation or multiplication on his own farm. Sale of breeding 
stock or animal reproductive material implies authorization to use it for agricultural pur-
poses (but not sale). 
[4(1)] Exclusion from patentability: No patenting plant & animal varieties or essential biologi-
cal processes for plant or animal production. 
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3.2 The Convention on Biological Diversity 
 
The Netherlands signed the Convention on Biological Diversity (CBD) in 1992 and be-
came a Party on the 12th July 1994. In 2002, the Netherlands hosted the 6th meeting of the 
Conference of the Parties (COP) to the Convention in The Hague.  
 
Article 6. General Measures for Conservation and Sustainable Use 
This article requires countries to develop national strategies, plans or programs for biologi-
cal diversity or adapt existing ones, and to integrate biodiversity considerations into 
relevant sectoral or cross-sectoral efforts. NvM as well as the NMP4 form the national 
strategy and priority programmes in the area of biodiversity. 
 BBI states that an inventory and analysis of the Netherlands national status and 
trends of agro biodiversity will be prepared by 2004. 
 
Article 8. In-situ Conservation 
The relatively few remaining traditional crops and characteristic breeds in the Netherlands 
are generally no longer competitive from a productivity perspective. In situ management of 
genetic resources focuses on the conservation and management of a limited number of rare, 
characteristic plants and animals, primarily in nature areas and by hobby breeders and 
farmers. The government supports the use of specific instruments, including subsidies, to 
promote in situ conservation as an element of an integrated, region-oriented approach to 
multifunctional agriculture. SoE cites the example of the new Subsidieregeling gebieds-
gerichtbeleid, which supports, among other activities, the development of regional 
specialty products, the maintenance of traditional regional specialty products, and the man-
agement, restoration and development of cultural-historical values. 
 SoE notes that local breeding and development of traditional crops and varieties in 
the context of in situ conservation can encounter problems with respect to existing legisla-
tion and regulations, in particular with respect to certification of planting seed for 
commercial sale (the Zaaizaad- en Plantgoedwet). SoE indicates that the need for possible 
amendment to the legislation will be studied, in an international context, noting that the 
European Commission has already initiated action in this area (Directive 98/95/EC treating 
'conservation varieties'). 
 
Article 8 (j). Traditional knowledge 
The Netherlands second report to the CBD notes that traditional knowledge is 'not relevant 
on the national level, but the Netherlands are addressing this issue at the international 
level'(p 28), and further notes that 'Dutch development cooperation policy gives priority to 
traditional communities and indigenous people'(p 31).  
 According to BBI, the Netherlands will contribute to the understanding of the poten-
tial commercial value of traditional knowledge, including through schools and training 
materials, and through the development of methods for the economic valuation of tradi-
tional knowledge. The Netherlands will also support studies and contribute to the work of 
WIPO on understanding the relationship between traditional knowledge and intellectual 
property rights. Particular attention will be given to capacity building for local groups, 
through bilateral cooperation (BBI). 
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Article 9. Ex-situ Conservation 
The Centre implements the Dutch program for ex situ conservation and use of crop and 
farm animal genetic resources (DWK 366), with a budget of 1.275.000 Euro, for Genetic 
Resources, The Netherlands (CGN). The objectives of the program are the maintenance 
and documentation of collections and stimulating their use, as well as providing support for 
international collaboration on genetic resources. CGN's collections are much more exten-
sive for plant species than for animals, for which genetic resources are maintained 
primarily by private sector breeders and the SZH. 
 The government has established the National Information Centre (see Article 17 be-
low), which is intended in part to promote cooperation between the different institutions 
(botanical gardens, universities, etc.) managing ex situ microbial, plant and animal collec-
tions.  
 
Article 15. Access and Benefit Sharing 
As the country of origin to only a few varieties or species, and since it advocates free ex-
change of genetic resources, the Dutch government does not consider it necessary to secure 
its own national sovereignty regarding access and use of genetic resources in its legislation 
(SoE). The Netherlands does not find it necessary to establish a PIC system of its own but 
considers MTAs to be an appropriate instrument to obtain concurrence on terms of transac-
tion of genetic resources, 'so long as they contain the right clauses, such as on the 
arbitration of disputes'(SoE). Examples of MTAs used by CGN are provided on the web-
site of the National Information Centre (www.absfocalpoint.nl).1 CGN does not claim 
ownership of its germplasm holdings, and requires the recipient, in the interest of contin-
ued free exchange, not to claim ownership over the material received or material that is 
essentially derived. The MTA used by CGN contains most of the elements suggested in the 
Bonn Guidelines, but no clauses on dispute settlement or on benefit sharing. The imple-
mentation of the IT-PGRFA and the development of a standard MTA will affect the use of 
MTAs in the Netherlands.2 
 The Netherlands has designated a National Focal Point (CGN, represented by Bert 
Visser) and a Competent National Authority (Marcel Vernooij).  
 The government considers that access, exchange and use of genetic resources by 
Dutch businesses, individuals or other organisations can probably be based on existing 
public law and regulations, supplemented by alternatives in the sphere of private law, such 
as MTAs (SoE). To promote the recognition of the principles of national sovereignty and 
prior-informed consent (as stipulated in Article 15 of the CBD) of genetic resources in 
other countries, the government calls on the private sector, individuals and other organisa-
tions to act carefully with respect to international and national regulations in other 
countries. The government has stimulated the development of codes of conduct, which is 
also to be one of the tasks of the national Genetic Resources Platform (SoE). A Code of 
Conduct for Botanical Gardens in The Netherlands: Compliance with the CBD has been 
formulated. Based on such a code, the botanical gardens will commit to the exchange of 
                                                     
1 MTAs are also available on the website for the Fungal Biodiversity Centre (Centraal Bureau vor Schimmel-
cultures, CBS). CBS prohibits distribution to third parties and use of the material for commercial purposes 
without permission of the legal owner. 
2 See section 2.3 
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material in accordance with the CBD (section 3.3. version). In addition, BBI indicates that 
a code of conduct for the use of genetic material originating from developing countries will 
be developed during the period 2002-2006, and applied on a trial basis, to those countries 
with which the Netherlands has signed a Sustainable Development Agreement (p. 44).  
 BBI states that the government is prepared to commit itself to more 'far-reaching 
measures' if the (voluntary) Bonn Guidelines do not lead to an effective sharing of the 
benefits arising from the use of genetic resources (BBI, p. 44). The example is given of a 
legally binding instrument, at least at the EU level. Such an instrument could include fur-
ther detailed agreements on how to deal with genetic components and on mechanisms for 
establishing the origin of genetic resources when IPRs are requested. 
 In addition, BBI indicates the Netherlands will advocate (though not require) that the 
country of origin be stated on the claim to intellectual property of plants and animals (p. 
44) which is also reflected in the EU Directive 98/44/EC. As discussed in Section 2.6, the 
formulation and force of such a requirement has been proposed by the EU in such a way as 
to avoid conflict with TRIPS and UPOV by not making it a condition for granting IPR pro-
tection. Although not yet implemented, such a policy stance can be seen as supporting 
implementation of the Bonn Guidelines and Article 15 of the CBD. 
 
Article 17: Exchange of information 
The National Information Centre for Genetic Resources (www.absfocalpoint.nl) has been 
established to support the national and international exchange of information on ex situ 
collections, contributing also to the implementation of Article 17 (see table 1). 
 
Article 16. Technology Transfer & Article 18. Technical and Scientific Cooperation 
The Netherlands collaborates internationally on issues related to biodiversity and genetic 
resources, contributing to Article 16 on Technology Transfer and Article 18 on Technical 
and Scientific Cooperation. SoE states that the Dutch government will, through bilateral 
and multilateral programs, 'facilitate an increase in the capacity of institutions in develop-
ing countries and central/eastern Europe with inadequate infrastructures and limited 
capacity for managing genetic resources' 
 On the international level, the Netherlands contributes to the implementation of the 
CBD through multilateral cooperation through: 
- the FAO, including the FAO/NL partnership program, for which agricultural biodi-
versity is one of the three major areas of focus; 
- financial support to the development of a global strategy on farm animal genetic re-
sources, and advocates assisting developing countries in the use and further 
development of their breeds of farm animals, in coordination with the FAO; 
- financial support to the international conservation and use of genetic resources by the 
CGIAR and its 16 Future Harvest Centres, including the International Plant Genetic 
Resources Institute (IPGRI). 
 
 On the European level, the government contributes to the development of a joint EU 
approach to genetic resources, including: 
- Reinforcing coherence of policy and regulations within the EU and in EU efforts 
within multilateral forums; 
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- Integrating the sustainable use of genetic resources into the Common Agricultural 
Policy and Common Fisheries Policy, based on the Biodiversity Action Plan for 
Economic and Development Cooperation; 
- Developing a joint approach to accessing genetic resources and a fair benefit-sharing, 
including a study of potential EU regulation; 
- Maintaining and reinforcing alternatives for supporting research and measures for the 
conservation and sustainable use of genetic resources (SoE); 
- Contributing financially to the establishment of a European Regional Focal Point, 
coordinating the conservation and sustainable use of animal genetic resources, and 
supporting the information exchange. 
 
CGN is also involved in a number of international cooperation initiatives:  
- active participation in the European Cooperative Programme of Crop Genetic Re-
sources Networks (ECP/GR) and in corresponding efforts for the conservation of 
animal genetic resources, including support for the establishment of a European Re-
gional Focal Point to co-ordinate the approach of individual countries and support 
the exchange of knowledge and information; 
- coordination of the EU-funded project EPGRIS - the European Plant Genetic Re-
sources Information Infra-Structure. This project will establish an infrastructure for 
information on plant genetic resources that are maintained ex situ in Europe, both 
through support for National PGR Inventories, and by creating a European PGR 
Search Catalogue with passport data on ex situ collections maintained in Europe 
(EURISCO). 
 
 With respect to bilateral cooperation, the government has stated that the Netherlands 
will work more intensively with a number of countries. At this point, LNV supports CGN 
in its collaboration on the development of a national program for genetic resources man-
agement in Bhutan. In general, the government considers that a joint effort towards further 
development of Codes of Conduct and Material Transfer Agreements is advisable. 
 The government also supports a number of international research collaboration initia-
tives, including: 
- research on participatory enhancement of managing vegetable and poultry genetic re-
sources by communities in Indonesia, Cambodia and the Philippines (PEDIGREA 
project; DLO/CGN with local civic society organisations); 
- research on biotechnology, plant breeding and seed technology for Indonesian horti-
culture (BIOBREES and HORTIN projects); 
- research and dissemination of information on useful plants in South East Asia 
(PROSEA) and also Tropical Africa (PROTA; Wageningen University).  
 
Article 19. Biotechnology 
The Netherlands became a Party to the Cartagena Protocol on Bio safety on the 8th Janu-
ary 2002. 
 The Netherlands is also guided by European Directive 98/95/EC, amending a number 
of previous Directives, which in its article 6 establishes that 
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'In the case of a genetically modified variety within the meaning of Article 2(1) and 
(2) of Council Directive 90/220/EEC of 23 April 1990 on the deliberate release into 
the environment of genetically modified organisms, the variety shall be accepted 
only if all appropriate measures have been taken to avoid adverse effects on human 
health and the environment' (Article 6, 1.4).' 
 
 The government indicated in an Integrated Policy Document on Biotechnology (Sep-
tember 2000) that the Netherlands encourages research on the alternatives provided by 
gene technology for food crops in developing countries.' 
 
 
3.3 International Treaty on Plant Genetic Resources for Food and Agriculture (IT-
PGRFA) 
 
The Netherlands promoted and was closely involved in the negotiations by which the In-
ternational Undertaking evolved into the IT-PGRFA, signing this treaty on 6th June 20021. 
Implementation of the IT-PGRFA is a priority for the Dutch government, which 'will re-
new its efforts to achieve a speedy ratification and implementation' (SoE). For 
implementation of the treaty, The Netherlands will continue to advocate close collabora-
tion between the FAO, the CBD and the CGIAR. 
 
Part II: General Provisions 
General obligations under Part II of the IT-PGRFA on conservation, exploration, collec-
tion, characterization, evaluation and documentation of PGRFA (article 5); sustainable use 
(article 6) national commitments and international collaboration (article 7) and technical 
assistance (article 8) overlap with obligations under the CBD. Many of the general activi-
ties described in sections 2.1 as well as the more specific ones mentioned in 2.2 thus 
contribute to their fulfillment. This work is also directly linked to and should facilitate the 
implementation of the Global Plan of Action. 
 Articles 5 and 6 of Part II of the IT-PGRFA allow a significant degree of flexibility 
in the interpretation of the specific obligations of contracting parties. Article 5 includes a 
long list of activities relating to both in situ and ex situ activities but Contracting Parties 
may determine which of these are deemed to be 'appropriate'. Article 6 includes a wide 
range of policy and legal measures that 'may' be promoted.  
 
Part IV: The Multilateral System on Access and Benefit-Sharing (MS). 
The Netherlands is obliged to place the genetic resources of crops and forages listed in an-
nex 1 to the IT-PGRFA that it holds in the public domain at the disposal of the System, and 
encourage other holders in the Netherlands to do the same. The government is required to 
take the necessary legal or other appropriate measures to provide facilitated access to other 
Contracting Parties (and legal and natural persons under their jurisdiction) through the MS. 
According to SoE, the government is developing MTAs, with a distinction made between 
genetic material for which the government bears exceptional responsibility, and genetic 
                                                     
1 Source: CGRFA website at www.fao.org/ag/cgrfa 
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material with primarily a commercial interest. Pending the ratification of the IT-PGRFA 
and the negotiation of a standard MTA for the MS, the Netherlands will then ensure that 
this is applicable for material held in the public domain in the Netherlands falling under the 
public domain (CGN). Recourse is already available under the Dutch legal system, consis-
tent with applicable jurisdictional requirements, in case of contractual disputes arising 
under such MTAs. 
 It is important in the context of this policy and the IT-PGRFA to define clearly, 
which genetic resources available in the Netherlands fall in the public domain. This issue 
may be handled by the Genetic Resources Platform and may also be dealt with in a con-
tract (convenant) between LNV and CGN. 
 In ratifying the IT-PGRFA, the Netherlands will agree to share fairly and equitably 
the benefits arising from the use of plant genetic resources for food and agriculture under 
the MS, including commercial benefits. This would be achieved through the exchange of 
information, access to and transfer of technology, capacity building, and the sharing of the 
benefits arising from commercialisation. As mentioned in section 1.3, this means that a re-
cipient who commercializes a product incorporating material (including 'genetic parts and 
components') from the MS must pay an equitable share of the benefits arising from the 
commercialisation of that product, except when it is available without restriction to others 
for further research and breeding.  
 Considering that plant varieties are not patentable in the Netherlands, the strongest 
form of intellectual property rights to be applied to plant varieties are Plant Breeders 
Rights under the UPOV Convention (1991 Act). As mentioned in section 1.5, an exception 
to Plant Breeder's Rights is made for private, non-commercial and experimental acts, as 
well as for acts done for the purpose of breeding other varieties (i.e. the breeders exemp-
tion). Thus, any commercialized variety incorporating plant genetic resources accessed 
from the MS in the Netherlands will still be available for further research and breeding; 
sharing the benefits of commercialisation through a contribution to the financial mecha-
nism will only need to be encouraged, not required by law. This issue is not mentioned 
explicitly in policy documents and the form by which such encouragement should take 
place has also not yet been defined. 
 SoE notes that the government seeks an integrated approach, 'generating as many 
agreements as possible on the level of organisms and their reproductive parts, instead of 
hereditary material.'  
 According to BBI, the Netherlands will advocate that the country of origin be stated 
on the claim to intellectual property of plants and animals (p. 44). This can be interpreted 
as a step to ensure implementation of Articles 12.3(d) and 13.2(d) of the IT-PGRFA. 
 
Part V: Supporting Components 
Other obligations include supporting international structures for the conservation and sus-
tainable use of PGRFA such as the GPA and relevant networks such as ECP/GR, and 
providing financial resources for the implementation of the IT-PGRFA. The National In-
formation Centre on Genetic Resources and the proposed Genetic Resources Platform can 
potentially contribute to meeting general obligations under the IT-PGRFA.  
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3.4 Intellectual Property Rights agreements 
 
TRIPS and UPOV 
The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) requires 
in Article 27.3 (b) that some form of intellectual property protection of plant varieties be 
provided, either by patents or by an effective sui generis system or by any combination 
thereof. The TRIPS requirement for intellectual property protection of plant varieties is ful-
filled by the Netherlands through its membership of UPOV (1991 Act), as an effective sui 
generis system of protection for plant varieties. The UPOV Convention in the Netherlands 
is implemented through the Zaaizaad- en Plantgoedwet. 
 Moreover, the Netherlands considers that the protection of breeders' rights is impor-
tant to all countries, and endeavours to attain acknowledgement of UPOV as one of the 
effective sui generis systems for protection for plant varieties within the TRIPS Agree-
ment. This position is based on the argument that discrepancies between a different sui 
generis system and the principles of the UPOV system can obstruct trade and the exchange 
of planting material (SoE, BBI).  
 
EU Directive 98/44/EC 
As a member of the European Union (EU), patent law on agricultural biological material in 
the Netherlands must conform with EU directive 98/44/EC, which provides for patent pro-
tection of biotechnological inventions, including biological material (such as gene 
sequences) which is isolated from its natural environment or produced by means of a tech-
nical process…even if it previously occurred in nature'. In 1998, The Netherlands 
supported by Italy and Norway, objected to this guideline, declaring that it should be de-
clared invalid and that the right to patents in the field of biotechnology should be restricted 
to methods and not include products (Tvedt 2002). The European Court of Justice rejected 
the Dutch appeal for annulment, and the Netherlands remains obliged to implement the 
guideline. 
 In 1999, the Dutch government submitted proposed legislation to the Parliament, 
which approved the proposal in April 2003. However the Senate, given the controversial 
nature and simultaneous change in government, never approved the bill.1 In July 2003, the 
EC declared that it would take the eight remaining member states, including the Nether-
lands, that had not implemented Directive 98/44, to court.2  
 
 
3.5 Concluding remarks 
 
The Netherlands participates in all of the instruments described in this document and con-
siders that 'international obligations regarding intellectual property, trade, agriculture and 
biodiversity are mutually reinforcing'. The Dutch government contributes to the work of 
regional and international fora in this regard and also collaborates bilaterally. 
 
                                                     
1 See Ministry of Economic Affaires (2003) 
2 European Commission Press Release IP/03/991, 10 July 2003. 
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- Implementing the Multilateral System (MS): The implementation of the IT-PGRFA is 
a priority for the Dutch government and will require appropriate integration into na-
tional law. Many issues addressed by the IT-PGRFA, especially regarding benefit 
sharing, will be addressed by the Governing Body at its first meeting. A review of 
the status of ex situ plant collections in the Netherlands may be necessary in order to 
determine which collections will form a part of the MS. As indicated above, it is im-
portant to define clearly which genetic resources available in the Netherlands fall in 
the public domain. Furthermore, the position of the government on the patentability 
of genetic material still needs to be addressed with respect to fulfilling obligations 
under EU Directive 98/44/EC. This will also have to involve attention for ensuring 
that the implementation of eventual provisions on the patentability of material from 
the MS is compatible with various IPR agreements. 
- Role of government: If the responsibility for policy implementation is to be left with 
the private and civil sector (SoE; see discussion under 2.1 above), the government 
will need to ensure a minimum level of infrastructure and public awareness on the is-
sue, as well as monitoring: 
- Infrastructure for genetic resources: The Genetic Resources Platform and the 
National Information Centre described in SoE are important mechanisms for 
fulfilling national obligations under these agreements. The stakeholder plat-
form, in particular, may provide a basis for building cohesion and consensus, 
and actively promoting much-needed linkages. 
- Awareness-raising: SoE notes 'an increasing social commitment to finding 
structural solutions to the loss of biodiversity and ways of achieving sustain-
able use of genetic resources'. But the extent to which the value of maintaining 
a variety of genetic resources on farm is recognized and promoted by govern-
ment policy seems rather unclear. This may suggest a further need for raising 
awareness of the importance of in situ conservation. 
- Monitoring implementation: The government proposes to set goals for the con-
servation and sustainable use of genetic resources that are as concrete as 
possible, by specifying its policy in detail (SoE). In the process, it is intended 
that indicators will be developed to monitor and evaluate progress, linked to 
the development of indicators at an international level. 
 
An open issue thus remains the extent to which encouragement and the facilitation of in-
formation exchange will ensure that policy is effectively implemented, as evidenced by the 
actions of the private sector, research organisations, civil society organisations and others. 
At some point, progress will have to be reviewed and assessed within the framework of 
monitoring activities. 
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4. Conclusions 
 
 
 
The international agreements relating to agricultural plant genetic resources were devel-
oped at different periods in time, and address an evolving policy agenda. Policy issues 
concerned initially promoting use of agricultural genetic resources for breeding efforts, re-
sulting in intellectual property protection systems. Relevant international agreements 
include the International Convention for the Protection of New Varieties of Plants (the 
UPOV Convention), the Agreement on Trade Related Aspects of Intellectual Property 
Rights (TRIPS). Growing awareness of loss of agricultural genetic resources led to the 
FAO Global Plan of Action on Plant Genetic Resources (GPA), and more recently the In-
ternational Treaty on Plant Genetic Resources for Food and Agriculture (IT-PGRFA). 
These instruments focus essentially on conservation concerns and are more closely related 
to the Convention on Biological Diversity (CBD). One of the strategic pillars of the CBD 
is the promotion of conservation through the sharing of economic benefits from using the 
genetic resources with those countries and communities responsible for the conservation. 
The IT-PGRFA recognises though the special circumstances of most agricultural genetic 
resources; they have long been exchanged locally and internationally (in some cases for 
centuries) meaning that the difficulty in designating providers of these resources should not 
restrict their further exchange. 
In general, the agreements are complimentary. The IT-PGRFA and the CBD recog-
nise the common property nature, whether national or international, of existing plant 
varieties and establish conditions for their international exchange for use in breeding ef-
forts. UPOV and TRIPS have allowed the creation of (intellectual) property rights, to be 
held by individual stakeholders such as companies, insitutes and individuals, over newly-
created varieties. Uncertainties remain though as to the terms for access and exchange to 
some plant genetic resources which are not covered by the IT-PGRFA and also potentially 
not by the CBD. 
 The issue of primary attention concerning the relationship between the various 
agreements is that of ensuring that national/collective rights established by the IT-PGRFA 
and the CBD are respected by recipients of genetic resources. The current strategy, after 
much international debate, is to rely on contractual arrangements between providers and 
receivers of material, such as material transfer agreements (MTA) with as few changes to 
IPR systems as possible. Such changes would be admittedly complicated and would gener-
ally necessitate amendments to TRIPS and possibly other agreements. The example of the 
disclosure of origin 'requirement' proposed by the EC in its Directive 98/44/EC, as well as 
to the TRIPS Council, is thus an example of a legislative measure within the realm of intel-
lectual property to support the IT-PGRFA and CBD, while carefully avoiding conflicts 
with TRIPS. 
 The Netherlands has played an active role in the development and implementation of 
these various international instruments. The government considers that the international 
obligations are 'mutually reinforcing'. At the same time, policy in the Netherlands has rec-
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ognised the need for some kind of framework to ensure that private actors respect the pro-
visions of the CBD and the IT-PGRFA as represented in terms of MTAs or other contracts. 
To this end, the government has supported the creation of a platform on genetic resources 
and the development by stakeholders of codes of conduct. The Netherlands has also sup-
ported at European level the requirement for disclosure of origin of biological material in 
patent applications. 
 The Netherlands is thus an example of a country of the North trying to promote a so-
lution with minimal adjustments to existing IPR agreements which many developing 
countries would prefer to see. At this point, it is difficult to predict whether this approach 
will achieve the results desired by various stakeholders. Recipients of material certainly 
have an incentive to avoid new requirements. If this becomes apparent, pressure may in-
crease for further adjustments to IPR regimes. But recipients of genetic resources can also 
be expected to consider this incentive against other concerns such as the increasing trans-
action costs for accessing genetic resources and alternatives. It is possible that many users 
will decide that the increasing costs of these resources are not worth the potential benefit. 
The resources in question might then be used less but their benefits shared more widely. 
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Annex 1 Key concepts and definitions 
 
 
 
Key concepts: 
 
Mutually Agreed Terms: 'For access to be on 'mutually agreed terms' (MAT), both supplier 
and recipient must agree to the terms, thus providing an opportunity for the providing 
country to negotiate a share of the benefits derived from the use of the genetic resources. 
Usually this implies a contractual arrangement, executed on a bilateral basis. The contract 
often takes the form of a 'Material Transfer Agreement' (MTA) setting out the agreed terms 
on which the genetic material is transferred. The MTA may specify the permitted or pro-
hibited uses of the genetic resources provided, including whether or not it may be 
commercialized; any rights which may or may not be taken out over the resource or its de-
rivatives; and the benefits that are to be shared' (Cooper 2002).  
 
Prior Informed Consent: 
 
'…means that the responsible authority of the providing country can decide to grant 
or refuse access following a request from the applicant. In the application, the appli-
cant may be required to provide information concerning the genetic resources 
required and the purpose for which they are required, as well as any proposal for 
benefit-sharing. As part of the PIC procedure, the responsible authority may consult 
with indigenous and local communities, or other stakeholders, concerned' (Cooper 
2002). 
 
Definitions: 
 
Sui generis: from Latin, meaning literally, 'of its own kind'. 
 
Sui generis systems: Latin for 'systems of their own kind'. This allows (WTO) members to 
be appropriately original and resourceful in designing these laws, no doubt so that the laws 
are effective in achieving desired objectives (Mangeni 2000). 
 
Plant genetic resources for food and agriculture: any genetic material of plant origin of ac-
tual or potential value for food and agriculture. (Article 2 of the IT-PGRFA) 
 
Genetic material: any material of plant origin, including reproductive and vegetative 
propagating material, containing functional units of heredity. (Article 2 of the IT-PGRFA) 
 
Variety: a plant grouping, within a single botanical taxon of the lowest known rank, de-
fined by the reproducible expression of its distinguishing and other genetic characteristics. 
(Article 2 of the IT-PGRFA) 
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Variety: applies to any cultivar, clone, line, stock or hybrid which is capable of cultivation 
and which satisfies the provisions of subparagraphs (1)(c) and (d) of Article 6, i.e. to be 
sufficiently homogeneous, having regard to the particular features of its sexual reproduc-
tion or vegetative propagation, and to be stable in its essential characteristics, that is to say, 
it must remain true to its description after repeated reproduction or propagation or, where 
the breeder has defined a particular cycle of reproduction or multiplication, at the end of 
each cycle. (International Convention for the Protection of New Varieties of Plants, Act of 
1961, Article 2) 
 
Biotechnology: any technological application that uses biological systems, living organ-
isms, or derivatives thereof, to make or modify products or processes for specific use. 
(Article 2 of the CBD) 
 
Country of origin of genetic resources: country that possesses those genetic resources in 
in-situ conditions. (Article 2 of the CBD) 
 
Centre of origin: means a geographical area where a plant species, either domesticated or 
wild, first developed its distinctive properties. (IT-PGRFA Article 2) 
 
Country providing genetic resources: country supplying genetic resources collected from 
in-situ sources, including populations of both wild and domesticated species, or taken from 
ex-situ sources, which may or may not have originated in that country. (Article 2 of the 
CBD) 
 
Genetic material: any material of plant, animal, microbial or other origin containing func-
tional units of heredity. (Article 2 of the CBD) 
 
Genetic resources: means genetic material of actual or potential value. (Article 2 of the 
CBD) 
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Annex 2 Timeline 
 
 
 
1961 Adoption of the UPOV Convention 
  | 
  | 
  | 
1978 1978 Act of the UPOV Convention 
  | 
  | 
1981 1978 Act of the UPOV Convention entered into force 
 
1982 
 
1983 FAO Commission on PGR established & IU adopted 
  | 
  | 
  | 
1989 Emergence of concept of 'Farmers' Rights' in IU negotiations (FAO Conf. Res. 5/89) 
 
1990 
 
1991 1991 Act of the UPOV Convention 
 
1992 UNCED – signing of CBD by 150+ states 
 
 Entry into force of CBD (Nairobi final act) 
 Decision to revise the IU in harmony with CBD 
 
1994 Adoption of the TRIPS agreement 
Signing of agreements by CGIAR Centers creating the International Network of Ex Situ Collec-
tions under the Auspices of FAO  
 
1995 Entry into force of TRIPS 
 
1996 Leipzig Conference – adoption of the GPA 
 
1997 
 
1998 1991 Act of the UPOV convention entered into force 
 
1999  
 
2000 Bonn Guidelines on access and benefit-sharing developed 
 
2001 Adoption of the IT-PGRFA 
  | 
  ? Entry into force of the IT-PGRFA 
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Annex 3 Legal Instruments relating to Plant Genetic 
Resources: Some relevant texts on internet 
 
 
- Convention on Biological Diversity (1992) www.biodiv.org/convention/articles.asp 
 
- Global System on Plant Genetic Resources www.fao.org/ag/cgrfa/PGR.htm 
 
- International Treaty on Plant Genetic Resources for Food and Agriculture (2001) 
ftp://ext-ftp.fao.org/waicent/pub/cgrfa8/iu/ITPGRe.pdf 
 
- Access and benefit-sharing as related to genetic resources. Decision VI/24 of the 
Conference of the Parties to the Convention on Biological Diversity including the 
Bonn Guidelines on Access and Benefit-Sharing (2002) 
www.biodiv.org/decisions/default.asp?dec=VI/24 
 
- Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS, 1995) 
www.wto.org/english/tratop_e/trips_e/t_agm0_e.htm  
 
- International Convention for the Protection of New Varieties of Plants, Act 1991, 
(UPOV 1991) www.upov.org/eng/convntns/1991/content.htm 
 
- International Convention for the Protection of New Varieties of Plants, Act 1978, 
(UPOV 1978) www.upov.org/eng/convntns/1978/content.htm 
 
- EU Directive 98/44/EC http://europa.eu.int/eur-
lex/pri/en/oj/dat/1998/l_213/l_21319980730en00130021.pdf 
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Annex 4 Crops included in the Multilateral System of 
the International Treaty on Plant Genetic Re-
sources for Food and Agriculture (IT-
PGRFA)1 
 
Food crops 
 
Crop Genus Observations 
Breadfruit Artocarpus Breadfruit only 
Asparagus  Asparagus  
Oat Avena  
Beet Beta  
Brassica com-
plex 
Brassica et al. Genera included are: Brassica, Armoracia, Barbarea, Camelina, 
Crambe, Diplotaxis, Eruca, Isatis, Lepidium, Raphanobrassica, 
Raphanus, Rorippa, and Sinapis. This comprises oilseed and 
vegetable crops such as cabbage, rapeseed, mustard, cress, 
rocket, radish, and turnip. The species Lepidium meyenii (maca) 
is excluded. 
Pigeon Pea Cajanus  
Chickpea Cicer  
Citrus Citrus Genera Poncirus and Fortunella are included as root stock. 
Coconut Cocos  
Major aroids Colocasia,  
Xanthosoma 
Major aroids include taro, cocoyam, dasheen and tannia. 
Carrot Daucus  
Yams Dioscorea  
Finger Millet Eleusine  
Strawberry Fragaria  
Sunflower Helianthus  
Barley Hordeum  
Sweet Potato Ipomoea  
Grass pea Lathyrus  
Lentil Lens  
Apple Malus  
Cassava Manihot Manihot esculenta only. 
Banana /  
Plantain 
Musa Except Musa textilis. 
Rice Oryza  
Pearl Millet Pennisetum  
Beans Phaseolus Except Phaseolus polyanthus. 
Pea Pisum  
Rye Secale  
Potato Solanum Section tuberosa included, except Solanum phureja. 
Eggplant Solanum Section melongena included. 
Sorghum Sorghum  
                                                     
1 Source: Annex 1 of the IT 
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Triticale Triticosecale  
Wheat Triticum et al. Including Agropyron, Elymus, and Secale. 
Faba Bean / 
 Vetch 
Vicia  
Cowpea et al. Vigna  
Maize Zea  Excluding Zea perennis, Zea diploperennis, and Zea luxurians. 
 
 
Forages 
 
Genera Species 
LEGUME FORAGES 
Astragalus  chinensis, cicer, arenarius 
Canavalia  ensiformis 
Coronilla  varia 
Hedysarum  coronarium 
Lathyrus  cicera, ciliolatus, hirsutus, ochrus, odoratus, sativus 
Lespedeza  cuneata, striata, stipulacea 
Lotus  corniculatus, subbiflorus, uliginosus 
Lupinus  albus, angustifolius, luteus 
Medicago  arborea, falcata, sativa, scutellata, rigidula, truncatula 
Melilotus  albus, officinalis 
Onobrychis  viciifolia 
Ornithopus  sativus 
Prosopis  affinis, alba, chilensis, nigra, pallida 
Pueraria  phaseoloides 
Trifolium  alexandrinum, alpestre, ambiguum, angustifolium, arvense, agrocicerum, 
hybridum, incarnatum, pratense, repens, resupinatum, rueppellianum, 
semipilosum, subterraneum, vesiculosum 
GRASS FORAGES 
Andropogon  gayanus 
Agropyron  cristatum, desertorum 
Agrostis  stolonifera, tenuis 
Alopecurus  pratensis 
Arrhenatherum  elatius 
Dactylis  glomerata 
Festuca arundinacea, gigantea, heterophylla, ovina, pratensis, rubra 
Lolium  hybridum, multiflorum, perenne, rigidum, temulentum 
Phalaris  aquatica, arundinacea 
Phleum  pratense 
Poa  alpina, annua, pratensis 
Tripsacum  laxum 
OTHER FORAGES 
Atriplex  halimus, nummularia 
Salsola  vermiculata 
 
